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Abstract 
When patients are discharged from hospital it is vital that the information regarding their 
medication is provided to the General Practitioner (GP) as accurately and efficiently as 
possible.  However errors frequently occur and the NHS is currently investigating how to 
improve discharge systems, one approach is to use pharmacists to write discharge 
prescriptions or To Take Out (TTOs).  The aim of the audit was to compare discrepancies on 
TTOs (To take out) between different transcribers: doctors, pharmacists and nurses and 
identify factors which are predictors of discharge discrepancies.  
Discharge summaries written by different transcriber groups from three study wards at one 
hospital were selected.  Discrepancies were identified by comparing the unauthorised TTO 
(TTO prior to final pharmacy check) to authorised TTOs, medical notes and prescription 
chart.  Discrepancies were classified according to the CHUMS classification procedure. 
Logistic regression was used to identify predictors of discrepancies. 
Two hundred and fifteen TTOs were included in the audit written by pharmacists, doctors 
and nurses (n= 85, 81 and 49, respectively).  Nearly 50% of TTOs contained at least one 
discrepancy, the most common of which was omission of a medicine.   The significant 
predictors of discrepancies were if a TTO was written by a nurse or a doctor or if there was 
more than three hours between an unauthorised TTO being authorised (Odds ratios were 
3.45, 2.26 and 3.88, respectively). 
 
Overall this study demonstrates the using pharmacist transcribers is at least as safe as 
previous systems and is unlikely to introduce additional discrepancies.  Alternative 
approaches which support the healthcare team to work closer together at the time of 
discharge should reduce delays authorising the TTO and reduce discrepancies.
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Chapter 1 
Hospital discharge in the UK 
The number of people admitted to hospital over the past 10 years has increased from 11 
million in 1998 to 13.5 million in 2008 (1).  With increasing numbers of people being 
admitted to hospital, and most significant increase in the number of hospital beds both the 
length of stay and the discharge process need to be as efficient as possible in order to mange 
this workload.  Moves towards economic rationalisation within the health care sector have 
put pressure on acute health care facilities to decrease hospital length of stay. 
 
The average length of stay in hospital has reduced from 8.4 days in 1998 to 5.7 days in 2008 
and this continue to reduce; although there is wide variation in length of stay between 
hospitals (2).  However, approximately 5% of patients discharged from NHS hospitals are 
readmitted as emergency admissions within 28 days, indicating that they were discharged too 
soon (3).  However there are many reasons that may cause readmission not related to 
premature discharge siuch as poor patient adherence to medication and adverse social 
circumstances.  Therefore, if reducing hospital stays is to be effective, discharge procedures 
must meet patient needs in order to avoid the potential adverse effects of a premature 
discharge.  Pharmacists are usually the last healthcare professional to review discharge 
information, and therefore have an important role to play in preventing hospital readmission 
and medication errors. 
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1.1 The importance of hospital discharge 
The discharge summary is the main communication between a hospital and the General 
Practitioner (GP) regarding a patient’s discharge.  However a number of problems have been 
identified with discharge summaries including lack of timeliness and a lack of information 
(4),.  In addition, a 2009 report by the Care Quality Commission (CQC)  identified that 
prescription errors and a failure to review a patients medication after discharge was the fourth 
most common complaint to the National Patient Safety Agency (NPSA) (5).  Therefore there 
have been a number of attempts to improve discharge procedures from hospital.  
 
1.2 Discharge planning 
Discharge planning is not a new phenomenon, but was first suggested in the late 1800s by 
Lillian Wald (6).  The term was officially introduced to the NHS in the 1960s as hospitals 
started to focus on reducing the length of hospital stays and minimising costs. Discharge 
planning then became a standard procedure. 
 
Discharge planning is a routine process for healthcare systems in many countries (7), and it is 
an interdisciplinary process that helps patients and their families to manage at home 
following a hospital admission (8).  The Cochrane Collaboration defined the discharge 
planning process as, “the development of an individualised discharge plan for a patient prior 
to them leaving hospital for home” (7). 
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The discharge process varies from hospital to hospital, and it is not entirely evidence-based 
(9).  Its aims are: to reduce the length of stay; avoid unplanned readmissions; and to improve 
the co-ordination of services after discharge. It can be divided into the following steps (7):  
1. Pre-admission assessment 
2. Case finding on admission 
3. In-patient assessment and preparation of a discharge plan based on individual patient 
needs 
4. Implementation of the discharge plan 
5. Monitoring 
 
To achieve high quality discharge planning, the process should start before the patient is 
admitted to the hospital (10), and it should include the physical, psychological and social 
aspects of individual patient care (11).  
 
Physical aspects consider the medical condition of the patient and include consciousness, 
pain, wound management and mobility .  Psychological aspects include information about 
patient recovery at home in relation to their illness or procedure undertaken.  They will 
consider the needs of carers or relatives, information about follow-up appointments and 
appropriate transfer of care arrangements.  Social criteria comprise of suitable home 
transportation for the patient, and arrangement of suitable assessments in the home.  
 
The Cochrane Collaboration conducted a systematic review of discharge planning including 
trials up to 2009 (7).  They included 21 randomised controlled trials (RCTs) that compared 
individualised patient discharge plans with routine discharge plans.  They identified that 
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discharge planning reduced length of stay and readmission rates, but its affect on mortality, 
costs and health outcomes remains uncertain. A meta-analysis conducted by Philips et al. 
which investigated the effect of comprehensive discharge planning compared to usual care in 
older heart failure patients additionally reported an improvement in survival and reduction in 
costs (12). 
 
While comprehensive discharge planning is the aspiration for most hospitals, resource 
limitations have currently restricted its implementation.  In most instances the discharge 
summary remains the single most important document to provide information to next 
clinician following a hospital discharge. 
 
1.3 Development of hospital discharge summary 
In the early 1970s, a discharge summary was divided into two documents: an initial report 
that was sent to the GP by post within approximately four days of patient discharge, and a 
final report that was posted to the GP to arrive within 19 days of discharge (13).  Through the 
1980s and 1990s, discharge summaries were mainly handwritten by junior doctors at the end 
of the patient’s stay. The hospital sent a copy of the discharge summary by post to the GP, in 
addition to the patient being given a copy to hand deliver to the GP (14).  
 
In the 1980s the discharge summary was generally composed of four sections: personal 
details; general practitioner information; information given to patient; and details of 
discharge medication (15).  However, GPs felt that they needed more information to be 
included in the discharge report, such as consultant identification, diagnostic assessment, 
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information on drug reaction, and treatment on discharge.  Accordingly, the information 
within the discharge summary was improved to satisfy the needs of GPs.   
 
The increase in the amount of information contained within the discharge summary made it 
longer than the two pages it had previously been, which decreased its ease of use (14).  Van 
Walraven, Rokosh conducted a study to examine the quality of discharge summaries and 
concluded that when a discharge summary concentrates only on discharge information and is 
written on a maximum of two pages, it is easier to use and delivered to the GP more quickly 
(16).  Therefore to provide GPs with the information they require in a succinct format, details 
about a patient’s medication formed the discharge prescription, sometimes called a To Take 
Out prescription or TTO.  For the remainder of this report it will be referred to as a TTO.  
 
Historically, the TTO was sent to the pharmacy where it was clinically checked to ensure all 
prescribed medication was appropriate for the patient.   As part of this process medication 
that was no longer needed would be removed (17, 18).  To help clarify any uncertainty with 
GPs it was recommended that a list of stopped medication also be included on a TTO (17).  
 
Over time, the contents of the discharge summaries have changed as studies have examined 
their contents and quality. In 1999, Van Walraven and Rokosh (16) recommended that, in 
order to increase the quality of a discharge summary, it should contain: the admission 
diagnosis, which would clearly explain the reasons for admission and the patient’s 
complaints; pertinent physical examination findings, procedures, and complications 
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encountered in the hospital; discharge diagnosis; discharge medication; active medical 
problems at discharge; follow-up appointments; and any relevant advice (19). 
 
In the last ten years the concept of medicines reconciliation (MR) has been introduced.  The 
Institute for Health Improvement (IHI) defined medicines reconciliation as “being the 
process of identifying the most accurate list of a patient’s current medicines – including the 
name, dosage, frequency and route – and comparing them to the current list in use, 
recognizing and discrepancies, and documenting any changes, thus resulting in a complete 
list of medications, accurately communicated”(20).  Consequently in 2008 The National 
Prescribing Centre (21) suggested that in order to complete the reconciliation process 
effectively, a minimum dataset needs to be given in a discharge summary when moving a 
patient from one health provider to another, and that this information must include:  
1 Complete and accurate patient details i.e. full name, date of birth, weight if under 16 
years, NHS/unit number, consultant, ward, date of admission, date of discharge 
2 The diagnosis of the presenting condition plus co-morbidities 
3 Procedures carried out 
4 A list of all the medicines prescribed for the patient on discharge from hospital (and 
not just those dispensed at the time of discharge) 
5 Dose, frequency, formulation and route of all the medicines listed 
6 Medicines stopped and started, with reasons 
7 Length of courses where appropriate (e.g. antibiotics) 
8 Details of variable dosage regimens (e.g. oral corticosteroids, warfarin, etc.) 
9 Known allergies, hypersensitivities and previous drug interactions 
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10 Any additional patient information provided such as corticosteroid record cards, 
anticoagulant books, etc. 
 
Despite all the recommendations for the contents of a discharge summary, large variation still 
exists between hospitals and within hospitals (22).  There is still no adopted consensus on 
what must be included (23, 24).  If the right information is not included in a discharge 
summary it may have negative consequences for the patient. 
 
1.4 Problems with discharge summaries 
Inaccurate information in a TTO can mislead the GP, and may cause incorrect prescribing or 
even prescribing unwanted medicines.  In 2008 it was reported that most discharge 
summaries details about medication were incomplete or inaccurate (25).   
 
Traditionally, discharge summaries were handwritten documents transcribed from medical 
notes, which may explain the large number of problems identified and errors occurring 
within them (19, 26-28).  When a patient is admitted to hospital, some or all of the items 
mentioned previously in Section 1.3 Should be documented and written in the discharge 
summary.  Consequently, the GP should receive correct and clear information about their 
patient (14). 
 
However, handwritten discharge summaries have been reported to be difficult to read or 
illegible, increasing the likelihood of errors (29).  When writing is difficult to read it means it 
may not be used by healthcare staff in the future care of the patient (30).  
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The legibility of doctors’ handwriting was examined by Lyons et.al. (31); comparing their 
writing with other healthcare professionals and administrative staff.  The researcher 
contacted staff at three separate locations: the health authority headquarters, an accident and 
emergency department, and various departments in another hospital.  They were asked to 
complete a form that contained boxes for the respondent’s name, 29 alphabetical letters and 
digits from zero to nine.  All 92 participants were requested to write as they normally would, 
as this was to be used as an example to examine their handwriting.  The completed forms 
were scanned using the Teleform software package system, which translates handwriting to 
text for computer analysis, and highlights any poor, unreadable handwriting as an error.  The 
study showed that the doctors’ handwriting was generally poorer than other staff.  Previously 
it has been suggested that doctors take less time reading and writing documents compared to 
other staff (32).  
 
Handwritten discharges summaries often contain a number of errors, and several studies have 
mentioned that the most common error is missing information.  Paterson et al. (33) 
conducted an audit by sending a questionnaire to family physicians to investigate the 
completeness of handwritten discharge summaries.  They developed a standardised discharge 
summary form that was easy to complete; it included the minimum data needed by 
physicians, and was faxable.  However, before completing the new form, physicians needed 
to be trained on the new design.  The researchers were then able to judge whether or not the 
new standardised discharge summary was beneficial.  They found it was easier to complete, 
took less time (as it was shorter than previous summaries), and was preferred by family 
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physicians.  Paterson et al. also sent questionnaires to physicians to assess 166 discharge 
summaries (138 were received by family doctors); among them, 92% were legible and 88% 
were complete.  The most common missing information was the doctor’s signature, patient 
diagnoses, test results, medications in hospital and follow-up plans.  In general, doctors 
preferred to receive standardised, well-structured discharge summary forms (19), and using 
such a form could increase the accuracy of the discharge summary because it would provide 
the hospital physician with specific spaces for information.  This reminds the physicians to 
fill in all the potentially missing information on the form.   
  
Many other problems arise with handwritten discharge summaries, mainly to do with the 
communication processes involved.  Sometimes it takes more than three weeks after a patient 
is discharged for the summary document to be received by the patient’s GP (34) and one 
study reported that 25% of discharge summaries sent by mail never reach the family 
practitioner(23).  Potentially more serious than this initial delay is information that might be 
missing from the summary, which typically includes patient demographics, dosage details, 
and extra medication sheets missed during transcription (26).  Many of these errors are not 
limited to handwritten discharge summaries and are not a consequence of poor handwriting, 
they are usually because of transcription errors (mistakes in copying information from in-
patient notes/prescription charts to the TTO) (14, 26).   
 
Normally, pharmacists and nurses are the practitioners who deal with discharge summaries, 
and so both are responsible for identifying any related medication errors in them.  As hospital 
doctors usually have a heavy workload, they normally rely on either pharmacists or ward 
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nurses to complete and correct the discharge summary (35-37).  However, if the writing is 
hard to read, then identifying the correct information will be difficult and time-consuming for 
those pharmacists and nurses.  Nurses and pharmacists may misunderstand the information 
and write incorrectly on the TTO, which can cause errors in subsequent care.  GPs still 
complain of low levels of accuracy in TTOs, and so some studies have recommended using a 
standardised paper form for typing the discharge summary but with a bar code for medication 
(17, 38).  Others suggest a standardised electronic system that allows hospital staff to type 
discharge summaries.  Both of these obviate the problems associated with handwriting (39). 
 
1.5 Electronic discharge summaries 
With the increased need for more accurate discharge summaries and improved 
communication with GPs, hospitals have started to utilise computer-based (typed) electronic 
discharge summaries (40-43).  Schabetsberger et.al.(40) stated that communication between 
healthcare providers through paper-based (typed) discharge letters is too slow and inferior in 
quality and suggested that by using electronic communication the quality of the discharge 
letter will improve.   
 
The national report “A Spoonful of Sugar” stated that the hospital discharge process should 
not be delayed now that a patient’s medication details are available on request and at their 
bedside, improve the accuracy and the quality of discharge information, also to support 
dispensing for discharge schemes (44).  As electronic communication is much quicker than 
by post, the discharge summary can be checked by the GP almost immediately.  On the other 
hand, any fault in the electronic system/maintenance will delay the ability to view the 
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information.  In addition the creation of an electronic discharge summary is still based on 
handwritten notes, so the information needs to be transcribed by medical or non-medical staff 
into a computer (19); this process still carries risks and medical errors may appear due to 
transcription process. 
 
O’Leary conducted a study showing that using an electronic discharge summary improved 
the quality and timeliness of the discharge summary (45).  A retrospective study comparing 
966 handwritten discharge summaries with 842 electronically typed ones was carried out in 
an Australian metropolitan hospital (26).  The medication sections on both types of discharge 
summary (hand written or typed) were transcribed from in-patient records.  The study found 
that in the handwritten and typed medication sections, the transcription errors were 
equivalent; about 12% of the handwritten ones contained medication errors, against 13% for 
the electronic ones.  Omission of information was found to be the most common error.  
Unfortunately, this study was only conducted on one single hospital, which means that the 
staff dealing with the discharge summaries mostly repeated the same errors each time.  Also, 
there may be bias in comparing the handwritten system, which had been in use for a long 
time at this hospital, with a new electronic system, as the staff were unfamiliar with the new 
system and were therefore more likely to make some mistakes.   
 
Another study (19) comparing handwritten discharge summaries with electronic ones was 
conducted, where 245 in-patient discharge summaries were examined for documentation; 
151 (62%) were electronic and the remaining 94 (38%) were handwritten.  They identified a 
17% deficiency rate in electronic discharge summaries compared to 11% in handwritten 
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summaries.  Thus, the study showed that the electronic discharge summaries were not 
necessarily of better quality than the handwritten ones (19). 
 
As technology has improved more hospitals have adapted an electronic discharge process in 
an attempt to minimise errors and reduce delays.  By 1 April 2010 hospitals should must 
deliver patient discharge documentation to the GPs within 24h after patient discharge (46). 
1.6 Fully electronic discharge summaries 
A fully electronic discharge summary is one that can be typed on a computer and sent 
electronically to doctors or other staff to be signed and then released.  The processes involved 
in fully electronic discharge summaries vary between systems, but generally, an authorised 
sender (doctor, nurse, pharmacist) collates a patient’s data, creates a virtual discharge 
summary, and after approval, then sends it electronically to an identified receiver via a secure 
web portal system (40).  The receiver (doctor, nurse, pharmacist) then follows certain 
procedures to identify errors; s/he then sends an ‘error status’ response back to the sender or 
accepts and proceeds with the discharge summary (47). 
 
With advances in computerised system technologies and in network services, the use of 
electronic discharge summaries should contribute to better services for patients and improved 
communication between healthcare providers (48).  However fully electronic discharge 
summaries still have a number of potential limitations, such as the need for back-up systems 
in case of system failure (like power cuts, for example).  Also, the use of an electronic system 
requires staff training, and electronic systems themselves will need updating and 
maintenance.  There is also the problem of compatibility. Some systems may not be 
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compatible with others, whether in-house or external (34), and problems are still being 
reported with some of the programs used to create and write discharge summaries (49).  
 
A review of the progress of electronic discharge summaries in 2007 by Craig et.al.(48) 
reported that fully electronic systems facilitate the exchange of information and the discharge 
process, saving time and resulting in discharge summaries being legible, and thereby 
reducing the chance of duplication and errors.  However, building such a comprehensive 
system for displaying and communicating patient information between healthcare providers 
is expensive.  To date, most hospitals in the UK have not been able to adopt a fully electronic 
system.   
 
While there have been a number of developments in discharge summaries, it is clear that a 
number of errors or discrepancies still occur throughout the discharge process therefore it is 
important to explore these errors if systems are to be improved. 
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Chapter 2 
Medication errors 
The National Patient Safety Agency (NPSA) Report 2004 (UK) and the Institute of Medicine 
Report (IOM) Report 2000 (USA) both highlighted that medical errors cause a large number 
of deaths each year (50).  These reports recognised that the majority of errors were not the 
result of reckless behaviour on the part of health care providers, but occurred as a result of 
the speed and complexity of the medication–use cycle. 
 
Medication errors are the single most preventable cause of patient harm.  Medication errors 
are broadly defined as any error in the prescribing, dispensing, or administration of a drug, 
irrespective of whether such errors lead to adverse consequences or not.  The landmark IOM 
report estimated that errors in medical management lead to between 44,000–98,000 deaths in 
the US each year, though these figures have been questioned (51, 52). 
 
The number of deaths from medication errors is increasing year on year, and many of these 
may be preventable (44).  Medication errors can occur at any stage of the medication process, 
including prescribing, transcribing, dispensing, administering and monitoring (53).  
Alongside the heavy cost of life, the estimated financial cost for 450,000 preventable 
medication-related adverse events in American hospitals is $3.5 billion (51). 
 
In the UK, the NPSA (body of the Department of Health) was established in 2001 with a 
mandate to identify patient safety issues and find appropriate solutions, by collecting 
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information on medication errors.  The NPSA estimates that approximately 9% of in-patients 
are exposed to medication-related harm, and that most of these cases could be prevented.  
Between January 2005 and June 2006, there were around 60,000 incidents reported, 
estimated to cost the NHS more than £750 million (54, 55).  The NSPA has also stated the 
number of reported medication errors is likely to be an underestimate of the total number, as 
many people may be unaware that an error has occurred, or they may be reluctant to report it 
(56).   
 
One of the difficulties in this field is the variety of terms used in the definition and 
classification of medication errors.  A more recent definition of medication error as: A failure 
in the treatment process that leads to, or has the potential to lead to, harm to the patient’ has 
been proposed, along with a psychological approach to the classification of medication errors 
according to whether they are mistakes, slips, or lapses (52).  The NPSA defines a 
medication error as: “an error in the process of prescribing, dispensing, preparing, 
administrating, monitoring or providing medicine advice, regardless of whether any harm 
has occurred”.  Moreover, they classify medication errors under two groups: adverse events 
and near misses (i.e. where no harm has occurred or the incident has been averted). 
 
2.1 Identification and classification 
Medication errors can also be classified as psychological, modal, or contextual (57).  The 
psychological classification explains events in terms of human factors, such as knowledge, 
instead of types of errors, which makes this inappropriate for this study.  The contextual 
classification is concerned with the time and place of the error, and the medicines and people 
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involved in the incident, which does not cover all the aspects pertaining to medication errors 
in the discharge summary.  However, the modal classification is concerned with classifying 
medication errors based on the ways in which those errors may have occurred, such as 
omission, repetition, or substitution.  
 
Aronson classified medication errors in various ways: prescription faults, such as ineffective 
prescribing and under-prescribing; writing faults; formulation faults, such as the wrong 
strength; and dispensing and administering faults (58).  Another classification system 
developed by Ferner and Aronson classified medication errors according to whether they are 
mistakes, which are errors in planning or action (these can be knowledge-based or rule-
based); or slips and lapses, which are errors occurring during an action (slips through 
erroneous performance, and lapses through erroneous memory) (59).  Many studies have 
classified medication errors based on study purpose, and examples of different medication 
error classifications are provided in Figure 1. 
 
There are evidently many ways to classify medication errors.  They can also be based on a 
wide variety of other issues: such as whether a medication error is present or potential; on 
severity; preventability and ameliorability; on the level of disability caused; on the stage of 
medication; or based on the personal responsibility of the healthcare physician (60).  Dean 
classified medication errors based on severity to the patient.  She divided the assessment of 
severity vis-à-vis medication errors into three methods: actual patient outcome; subjective 
assessment of potential patient outcome; and on proxy indicators.  
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The objectives for creating a new assessment system for medication administration errors 
(MAEs) are to select an appropriate scale for measuring MAEs, to find the minimum number 
of stakeholders needed to make judgements, to determine how the profession of those 
stakeholder judges will affect the scores, and to assess the validity of the stakeholders’ 
scores.  Ten doctors, ten pharmacists, and ten nurses from different hospitals are recruited in 
Dean’s study.  Fifty cases are sent to them to assess, through the scoring system, and they are 
asked to make further comments.  To measure the validity of the scoring system, the cases 
include five classified as minor, five moderate, and six severe; this to allow them to assess 
the scoring system.  Two weeks after receiving the cases, each respondent was then sent ten 
of the original cases for reassessment. 
 
Dean suggested that if any four stakeholder judges (pharmacists, doctors and nurses) are used 
to score the severity of the medication error, then the scoring results should be generalisable 
to the results of any other judges from the same population.(61).  
 
Finally, The Care Home Use of Medicines Study (CHUMS) (62) investigated the prevalence, 
types and underlying causes of medication errors at residential and nursing care homes in 
three areas of England.  They classified the errors into prescribing, monitoring, dispensing 
and administration errors.  Within each of these areas there was more detailed classification 
such as omission, unnecessary drug, duplication, incorrect drug or dosage.  Since the current 
study is focused on prescribing errors, CHUMS classification provided the most 
comprehensive classification for prescribing errors compared to other errors reporting and it 
was suitable after some improvement and adopted to this audit as it cover all types that may 
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occur whilst prescribing or dispensing the medicines (see Appendix A for classification of 
discrepancies).
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Medication Errors 
classification 
Skill-based 
errors e.g. 
illegible hand 
writing 
Modal classification 
Contextual 
classification 
Technical 
errors 
Mistakes -errors 
in planning 
actions 
Skill-based errors 
in executing 
correctly-planned 
action  
Psychological 
Classification 
Omission 
Errors of 
integration or 
knowledge 
based errors 
e.g. drug 
allergy 
 
Commission 
e.g. incorrect 
written 
components 
Classification  
Major errors 
e.g. absence 
of any 
component of 
body of 
prescription  
Minor errors 
e.g. direction 
for use  
Repetition Omission 
Substitution 
2 1 
People 
involved 
Specific time Specific place 
Medicines 
Memory-based 
errors (lapses) 
Action-based 
errors (slips) 
Knowledge- 
based errors 
Rule-based 
errors 
Good rules not 
applied or misapplied Bad rules 
3 
4 
Figure 1 Examples of Medication Errors Classification Chart 
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2.2 Prescribing errors 
Prescribing errors may be defined as the incorrect drug selection for a patient.  Such errors 
can include the dose, quantity, indication, or prescribing of a contraindicated drug.  Lack of 
knowledge of the prescribed drug, its recommended dose, or lack of patient details can 
contribute to prescribing errors.  Other contributing factors include: 
 Illegible handwriting. 
 Inaccurate medication history taking. 
 Confusion with the drug name. 
 Inappropriate use of decimal points. A zero should always precede a decimal point 
(e.g. 0·1). Similarly, tenfold errors in dose have occurred as a result of the use of a 
trailing zero (e.g. 1·0). 
 Use of abbreviations (e.g. AZT has led to confusion between zidovudine and 
azathioprine). 
 Use of verbal orders(63). 
 
In a four-week UK prospective study of 36,200 prescriptions, 2% were found to have a 
prescribing error, 25% of which were potentially serious (52).  When only serious errors 
were examined, 58% of the errors originated in the prescribing decision and 42% in 
medication order writing.  This distribution is different from that seen in non-serious errors.  
Of further concern was the fact that the majority of errors were made by relatively junior 
medical staff, who are responsible for the majority of prescribing duties in hospitals  
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2.3 Dispensing errors 
Dispensing errors occur at any stage of the dispensing process, from the receipt of the 
prescription in the pharmacy to the supply of a dispensed medicine to the patient.  Dispensing 
errors occur at a rate of 1–24 % and include selection of the wrong strength or product.  This 
occurs primarily with drugs that have a similar name or appearance. Lasix® (frusemide) and 
Losec® (omeprazole) are examples of proprietary names which, when handwritten, look 
similar and further emphasise the need to prescribe generically.  In the US, the Food and 
Drug  Administration has insisted that the proprietary name of Losec® be changed as a result 
of a number of fatalities associated with this confusion. Elsewhere, the name Losec® 
remains.  Other examples of pairs of drugs with similar names where confusion occurs 
include amiloride 5 mg and amlodipine 5 mg tablets.  Other potential dispensing errors 
include wrong dose, wrong drug, or wrong patient, and the use of computerised labelling has 
led to transposition and typing errors which are among the most common causes of 
dispensing error(64) . 
 
Approaches to reducing dispensing errors include(52): 
 Ensuring a safe dispensing procedure. 
 Separating drugs with a similar name or appearance. 
 Keeping interruptions in the dispensing procedure to a minimum and maintaining the 
workload of the pharmacist at a safe and manageable level. 
 Awareness of high risk drugs such as potassium chloride and cytotoxic agents. 
 Introducing safe systematic procedures for dispensing medicines in the pharmacy. 
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2.4 Administration errors 
Administration errors occur when a discrepancy occurs between the drug received by the 
patient and the drug therapy intended by the prescriber (52).  Drug administration has long 
been associated with one of the highest risk areas in nursing practice, with the ‘five rights’ 
(giving the right dose of the right drug to the right patient at the right time by the right route) 
being the cornerstone of nursing education.  Drug administration errors largely involve errors 
of omission, where the drug is not administered for a variety of reasons.  Other types of drug 
administration error include an incorrect administration technique and the administration of 
incorrect or expired preparations (65). 
 
Causes of administration error included a lack of perceived risk, poor role models, and lack 
of available technology.  Mistakes tend to occur when drug preparation or administration 
involves uncommon procedures with causes including a lack of knowledge of the preparation 
or administration procedures and complex design of equipment.  In contrast, a major error 
rate of 0·19% in 30,000 cytotoxic preparations has been reported, suggesting that medication 
error rates may be lower in situations where intravenous drugs are administered in 
specialised units (52, 65).  While this rate may be interpreted as being low, if such a rate were 
to be extrapolated each year across a large clinical area, the numbers of patients affected 
would be significant.  Contributing factors to drug administration errors include a failure to 
check the patient’s identity prior to administration and the storage of similar preparations in 
similar areas (65). 
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Environmental factors such noise, interruptions whilst undertaking a drug round, and poor 
lighting may also contribute to these errors.  The likelihood of error is also increased where 
more than one tablet is required to supply the correct dose or where a calculation to 
determine the correct dose is undertaken (52).  
 
Approaches to reduce drug administration errors include (52): 
 Checking the patient’s identity. 
 Ensuring that dosage calculations are checked independently by another health care 
professional before the drug is administered. 
 Ensuring that the prescription, drug, and patient are in the same place in order that 
they may be checked against one another. 
 Ensuring the medication is given at the correct time. 
 Minimising interruptions during drug rounds. 
 
Clinical pharmacists are key to ensuring the safe use of medicines, and the current system 
where wards are visited daily by clinical pharmacists places these professionals in a good 
position to recognise particular training needs that can be addressed (52). 
 
2.5 Errors at discharge from hospital 
Researchers have used many ways to detect errors, including direct observations, 
unannounced control visits, and chart reviews (38).  Macaulay et.al. (66) ran a prospective 
audit for eight month intervals looking for errors in discharge summaries in the vascular 
surgical unit at the Aberdeen Royal Infirmary in the UK.  They found that of the 637 
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discharge summaries, 63 contained errors.  Of this number, 107 discharge summaries were 
produced by three consultants (2% of which contained errors), 200 were produced by one 
senior registrar (7% of which contained errors), 118 were produced by two registrars (10% of 
which contained errors), and 212 by senior house officers (junior doctors undergoing training 
within a certain specialty, 17% of which contained errors). 
 
McMillan et.al. (14) ran a study to identify the severity of errors in handwritten discharge 
summaries.  They compared the medications lists in referral letters from GP prior to 
admission with the medications used during admission.  They then compared the medicines 
listed on a drug chart with the medications listed on the discharge summary and identified in 
any discrepancies.  In that study, the errors were classified as potentially likely to cause 
readmission, potentially serious, potentially troublesome, and minor (unlikely to cause a 
significant problem).  The study identified 222 medication errors; 24 (10%) as being 
potentially serious, and 4 (2%) as having the potential to cause readmission. The 
prescriptions were written by consultants, registrars, house officers and medical students; all 
of them made errors, in differing percentages, but the house officer score was the highest 
with 73 errors, and only one consultant wrote a prescription without errors.  Many of the 
errors were preventable, and some of them had the potential to cause serious problems for the 
patient.  
 
Although junior doctors makes more medication errors it can be seen that medication errors 
are not limited to junior doctors; even consultants can make them (66). When the medical 
team decided to send a patient home, a junior doctor usually took responsibility for writing 
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the discharge summary.  It is clear that errors most often occurred when junior doctors wrote 
discharge summaries, more so than when consultants wrote them, so much care should be 
taken in reviewing a discharge summary before releasing it to the patient.  As doctors were 
the main professionals who writes discharge summaries more than other professionals most 
studies were examined medication errors on TTOs written by doctors and no more study 
examined medication errors on other healthcare professionals TTOs. 
 
2.6 Reasons for medication errors 
To find appropriate solutions for medication errors, the researcher must find the root of the 
problems that cause medication errors to happen in the first place.  There are many causes 
but most are related to pressured working environments, staff shortages, errors in patient 
medical histories, doctors with inadequate skills, knowledge or experience, and inadequate 
training to spot discrepancies (65).  When doctors rely on pharmacists and nurses to identify 
and correct errors due to workload pressures, deficiencies in communication among the 
parties can ensue, leading to errors (37).  Moreover, those being relied upon may misinterpret 
doctors’ notes, compounding existing errors (65). 
 
In order to overcome of medication errors, the healthcare professional roles (doctors, 
pharmacists and nurses) must be promoted to ensure appropriate involvement within the 
whole medication process.  This may involve changes to the traditional role adopted by each 
healthcare professional.
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Chapter 3 
Role of pharmacist  
3.1 Introduction 
While traditionally doctors and dentists were the only prescribers of medication, now other 
healthcare professionals have gained prescribing rights.  Pharmacist prescribing was first 
introduced in California in the late 1970s and was gradually extended to other American 
states. In 1998, pharmacists were allowed to prescribe under certain protocols in 17 states, 
and in Florida, pharmacists were able to prescribe from a limited range of medicines.  In the 
late 1990s, Dr June Crown wrote her final report for the NHS in the UK regarding the supply 
and administration of medicines; she recommended extending the authority to prescribe to 
other professionals (pharmacists and nurses), claiming this would be beneficial for all health 
services (67).  This authority to prescribe had been controlled so that each profession had a 
clearly specified range as to what could be prescribed. Previously, pharmacists in the UK 
were not allowed to write discharge prescriptions (TTOs), and doctors still had to sign and 
bear responsibility for the prescription (18, 68, 69).  However, the role of pharmacists in the 
UK began to change in the late 1990s in order to provide better services to patients, and one 
suggestion at that time was for pharmacists and other healthcare professionals to be involved 
in transcribing discharge prescriptions (TTOs) (68, 70). 
 
The initial results were positive; when pharmacists were involved in the discharge process 
and wrote discharge summaries, according to many studies, the pharmacists’ intervention 
reduced the number of medication errors in discharge summaries (71).  However, there is a 
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degree of variability between hospitals in the role of pharmacists writing discharge 
summaries for example each hospital has a different internal protocol for pharmacists to 
write discharge summary (68), and there is also variability in other healthcare professionals in 
accepting the new situation that pharmacists writing the discharge summaries for example some 
consultants may accept a medication ‘transcriptions’ signed by a pharmacist, especially one 
already prescribed by their team (72). 
 
Hospital discharge is a part of general discharge planning, and pharmacists can contribute to 
each part with other professionals.  The public conception of the pharmacy is that it involves 
dispensing at the point of discharge only; however, studies have shown that the pharmacist’s 
role begins at the point of admission.  Therefore, clinical pharmacists are in a position to help 
improve the discharge procedure by providing high quality information about the patient 
throughout his/her stay.  Brady et.al. defined pharmacy discharge as: “the discharge of a 
patient with the assurance that all pharmaceutical requirements including information are 
communicated in a safe, efficient and user-friendly manner” (73). 
 
Pharmacists have extensive and specialist knowledge regarding medication, and this allows 
them to intervene at various stages along the patient’s medical progression:  
1 Pre-admission (taking drug history) (74) 
2 In-patient (pharmacy round and counselling) (75) 
3 Out-patient pharmacy (dispensing and counselling) (75) 
4 During discharge process (reviewing discharge medication, transcribing discharge 
medication and writing discharge summary) (76) 
5 Post-discharge (extra counselling by phone (28, 77, 78) and home visits)  
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6 Community pharmacist (ensure medication adherence and regime) (79) 
 
In general, one role of the pharmacist is medicine reconciliation and this study will 
concentrate on one part of medical reconciliation process which is the role of pharmacists in 
discharge.  Pharmacists need more consideration regarding their role in writing discharge 
summaries, especially the section related to medication (the discharge medication list). 
 
3.2 Involvement of pharmacists in discharge summary and discharge prescription 
There has been positive feedback with regard to involving pharmacists in writing discharge 
summaries, encouraging those who work in pharmacy practices and pharmacy management 
to focus on the benefits when pharmacists write discharge prescriptions (TTO).  Other 
professionals may produce safer TTO and so further studies maybe needed to compare TTOs 
written by pharmacists to those written by others (doctors and nurses), also the disadvantages 
of pharmacists writing a discharge summary need to be determined.  The Audit 
Commission’s report “A Spoonful of Sugar” recommended that the duties of clinical 
pharmacists should include prescribing TTOs, however a clinical pharmacist has less patient 
contact than doctor and nurse, therefore it is possible that the pharmacists may be more likely 
to omit medication which patient have received on the ward.(80).  Many studies have 
examined this.  Hobson, Sewell (81) developed a questionnaire based on a literature review 
and reported on the advantages of pharmacist discharge prescription (TTO) transcription 
services (PDPTS).  The questionnaire included open and closed questions, which were 
designed to examine the overall impact of pharmacists writing discharge prescriptions 
(TTO).  The questionnaire was sent to 206 NHS Trusts, and the response rate was 66%; 63% 
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of the Trusts had at least one prescribing pharmacist, and 44% did not have any prescribing 
pharmacists.  However, in those Trusts that had prescribing pharmacists, those pharmacists 
wrote fewer than five prescriptions per day for their own wards.  This study showed that 
early in 2002, as a percentage, pharmacists were not greatly involved in writing discharge 
summaries, and about 23% of prescriptions needed contact with a doctor, either to correct 
errors or to clarify medication changes (75).  Woolfrey et.al. found that pharmacists prescribe 
drugs in 5% of cases after referral to a doctor, and in 10% of cases without reference to a 
doctor (82).  It is clear that pharmacists should contact the doctor regarding some medication 
while prescribing TTO therefore the prescribing process may be a team work process rather 
than individual process and each professional (doctors, nurses and pharmacists) may 
contribute in writing or correction the TTO. 
 
Marriott and Bessell (18) sent 167 questionnaires to 53 hospitals across Australia to explore 
the involvement of pharmacists in the discharge process. In each hospital, the questionnaire 
was sent to two doctors, four pharmacists, two nurses and two administrators.  Three focus 
groups were created, and included pharmacists, doctors, nurses and administrators.  Most of 
the responses were obtained from medium-sized hospitals, but most of the pharmacists who 
worked in large hospitals responded.  The authors reported that the pharmacists’ highest 
priority was discharge, compared to other healthcare professionals who rated discharge as 
medium-to-high priority.  They also found that inadequate communication and transfer of 
information between all groups dealing with the discharge summary was clearly one of the 
weaknesses in the discharge summary process.  In these hospitals, the focus group identified 
the pharmacist as the most suitable person to starts the discharge process and control the 
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whole discharge medication process.  In general, the study stated that the increased 
involvement of pharmacists in the discharge process was generally accepted, however, the 
researchers provided four questionnaires for pharmacists but only two questionnaires for 
other staff, and this may derail the results.   
 
Even though pharmacists pay more priority to the TTO among other professionals (doctors 
and nurses) it does not mean that they will not make mistakes while writing TTOs.  
Nevertheless, pharmacists currently contribute to the discharge process by checking the 
prescription, contacting the doctor prior to dispensing in order to clarify the orders, 
delivering medication to the patient, and counselling.  Additionally, pharmacists in some 
large public hospitals provide post-discharge and hospital-community pharmacy liaison 
services (18). 
 
Rahman et.al. conducted a study comparing discharge summaries written by doctors with 
those written by pharmacists.  The study consisted of two phases.  In Week One, the doctors 
wrote 128 discharge prescriptions (TTO), and in Week Two, the pharmacists wrote 133 
discharge prescriptions (TTO).  In Week One, all discharge prescriptions (TTOs written by 
doctors) were checked by the pharmacists before dispensing, and in Week Two, the doctors 
checked all the prescriptions written by the pharmacists for any errors before sending them to 
the normal dispensing process.  The pharmacists made 755 interventions in the doctors’ 
prescriptions, and the doctors made 76 interventions in pharmacists’ ones (83).  In its 
conclusion, the study stated that the pharmacists were better at writing discharge 
prescriptions (TTO); however, as the pharmacists have more experience in spotting errors, it 
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seems normal that they would spot errors in the doctors’ discharge prescriptions (TTO).  
Also, the doctors may have had a heavy workload and were not able to spend sufficient time 
on spotting errors in the pharmacists’ prescriptions in addition to low experience in spotting 
errors.  
 
Other evidence shows that pharmacists are five times more accurate in writing discharge 
summaries than doctors, and that pharmacists’ intervention can reduce drug-related-problems 
(DRP) (84, 85).  Moreover, Wood argued that discharge planning is better when pharmacists 
write discharge prescriptions (TTO), and that medical and nursing staff prefer pharmacists to 
write discharge prescriptions (TTO).  Wood also found that the estimated cost savings would 
be £3,900 every year for the two wards included in his trial because the pharmacists only 
requested medicines that were needed (75). 
 
The involvement of pharmacists in the discharge process is problematic, as there is a 
shortage in the number of qualified clinical pharmacists who can be involved; also, it means 
that the workload of the pharmacists will be increased (18).  However, increasing the 
involvement of pharmacists in the discharge process has some potential benefits for the 
health system.  It will: decrease need to contact doctors to ask for permission to write a 
discharge prescription (TTO) or to ask for correction and clarification of a prescription; 
decrease time pressure for both doctors and pharmacists; decrease patient waiting time for 
discharge medication; discontinue medication that is no longer required; decrease the time 
needed to discharge a patient; improve bed availability (18); and, critically, decrease 
medication errors in discharge prescription (TTO) (68).  Another suggestion mentioned is 
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that there is the chance to involve pharmacists, not only in the discharge process, but also in 
making advanced decisions regarding discharge.  
 
The above studies are also a stimulus to further examine the possibility of pharmacy 
prescribing, and to assess the general view of all stakeholders (pharmacists, nurses and 
doctors) about transferring the responsibility of writing and signing discharge prescriptions 
(TTO) from doctors to pharmacists (advantages and disadvantages). 
3.3 Pharmacist discharge counselling 
Al-Rashed (86) et.al. conducted a study to evaluate the value of pharmacist counselling prior 
to discharge for 43 study and 40 control patients.  They found that when a pharmacist 
counselled a patient about their medication and compliance, prior to discharge, it resulted in 
reductions in unplanned visits to the doctor and in readmission rates.  
 
Pharmacy services provided to patients vary from hospital to hospital, and there are no 
standards for the provision of such services (87).  Grimes et.al. conducted a trial examining 
the pharmacy services provided to patients by Accident and Emergency (A&E) departments 
from 36 public hospitals (87), by using semi-structured telephone interviews, and these 
showed that each hospital provides different pharmacy discharge services.  One quarter 25% 
of the A&E departments reported that they delivered clinical pharmacy services, and 15% 
reported that pharmacists were involved in admission and in noting the patient’s medication 
history. In one case, the hospital was able to communicate with the community pharmacy.  
However, there were marked differences in the location of the hospitals involved in the trial, 
and subsequently there were significant differences in the number of the cases admitted to 
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each hospital.  Thus, those hospitals receiving high numbers of cases may not have been able 
to provide full clinical pharmacy services during discharge.  Nevertheless, studies claimed 
that pharmacist discharge counselling shows promise in decreasing short-term readmission 
and decreasing medication errors, as well as decreasing drug side effects.  However no study 
examined the benefit of nurse advice during discharge and it is affect on quality of discharge. 
 
3.4 Post discharge counselling 
Some studies have stated that providing post-discharge support, such as home visits or 
frequent telephone contact, when combined with discharge planning, reduces unplanned 
readmission (7, 88).  As the discharge summary is part of the discharge planning process, and 
as pharmacists are involved in discharge summaries by transcribing the TTO, pharmacists 
may contribute to reducing hospital readmission, but further study needs to be conducted to 
prove this.  
 
Schnipper et.al. conducted a randomised trial that included 178 patients, all of whom were 
discharged from the Birmingham and Women’s Hospital, Boston (77).  The intervention 
group received pharmacist counselling on discharge and a phone call follow-up three to five 
days after discharge.  The control group proceeded through the usual care process-
medications were reviewed by a ward-based pharmacist and the patients received medical 
counselling by a nurse at the time of discharge.  The pharmacist interventions were focused 
on clarifying regimes, and potential and early side-effects, ensuring adherence, and providing 
patient counselling and/or physician feedback when possible.  The result was that 
preventable adverse drug events (ADEs) occurred in about 11% of the patients in the control 
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group but these decreased to about 1% in the intervention group.  However, in this study, the 
researchers’ follow-up was based on updates from GP appointments via a standardised e-mail 
form.  Consequently, those patients who visited their GP often and regularly may have had a 
better chance of eliminating medication errors due to more frequent GP advice.  
 
Similarly, in Melbourne, Australia, Vuong et.al. conducted a trial that included 160 patients 
in each patient group, and they aimed to identify the pharmacy services that improved the 
continuity of patient care (89).  The control group received standard care, which included 
discharge counselling, provision of compliance aids, and communication with healthcare 
providers if needed.  The intervention group received standard care plus a home visit within 
five days of discharge in addition to a telephone call eight to 12 weeks after discharge in 
order to assess the impact of the intervention on adherence and medication knowledge. The 
study showed that adherence had improved in the intervention group, which minimised 
medication misadventure after patient discharge.  
3.5 Community pharmacy 
Community pharmacists should co-ordinate with other pharmacy services provided by 
secondary or primary care services to ensure that patients receive appropriate healthcare. 
This co-ordination should supply the community pharmacists with information that ensures 
continuity of the patient care process (90).  Munday et.al. posted a questionnaire to all 
community pharmacists within the catchment area of Glasgow Royal Infirmary University 
NHS Trust.  A high 94% of community pharmacists wanted to receive reasons for drug 
therapy changes, but most of them did not receive the desired information (90).  Recently, 
studies have shown that GPs are still unaware of the supplementary role of community 
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pharmacists and their effect on healthcare services.  Al-Rashid showed that 9% of GPs 
agreed that the community pharmacist should receive a copy of the discharge information 
(91).  However, it seems that communication between hospital pharmacists and community 
pharmacists is weak (92), and this lack of information creates gaps in the information 
exchanged about a patient between the hospital and the community pharmacist.  In general, 
current levels of communication between hospital pharmacists and community pharmacists 
vis-à-vis patient data are low.  
 
Paulino et.al. conducted a trial that included 112 community pharmacists in several European 
countries: Austria, Denmark, Germany, the Netherlands, Portugal and Spain (93).  They 
studied the effect of community pharmacist intervention in preventing and resolving drug 
related problems (DRPs).  The patients were asked to identify DRPs through filling in a 
questionnaire.  Among the 435 patients included in this trail, 277 were identified as having 
DRPs; and the community pharmacists recorded 305 interventions for DRPs in 205 patients.  
However, applying such a study in a group of countries, which may have very different 
healthcare systems, may have biased the results.  Moreover, the community pharmacists only 
documented DRPs as provided by the patients, without clear explanations of whether or not 
these problems really were drug-related.  However, this study reveals the effect of 
community pharmacists in reducing DRPs. 
 
In general, community pharmacists need more information about patient medication, and the 
reasons for stopping or adding any new medications to a patient’s list. Updating community 
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pharmacists with new diagnoses (if they change) will give them more knowledge and 
confidence in serving their patients. 
 
At the end it is questionable whether involving pharmacists in discharge process can 
overcome many problems.  For example both pharmacists and doctors waste time checking 
and correcting prescriptions; this increases the workload for both pharmacists and doctors 
(and for nurses as well), decreases patient satisfaction, increases the patient’s waiting time 
for a prescription (75), and increases the hospitalisation period, consequently wasting 
financial resources. Such problems act as a stimulus for pharmacists to increase their 
involvement in the discharge process, and in particular in writing discharge summaries.  
Also, Cattell et.al. argued that when pharmacists transcribe discharge prescriptions (TTO), 
the dispensing time decreases from 240 to 177 minutes, which decreases the time of the 
discharge process from 460 to 322 minutes; this saves about £6 per patient through reissuing 
the patient’s own drugs (PODs) (94).  However most of the previous study investigated the 
role of pharmacists in hospital discharge by using questionnaires which is not reflect the true 
situation.  Therefore more studies are needed to investigate the pharmacy role in writing 
discharge summaries by checking and comparing errors percentage appears on the discharge 
summaries that written by different transcribers (doctors, pharmacists and nurses).
48 
3.6 Different healthcare prescriber 
Historically, doctors were the only authorized professionals allowed to write discharge 
medications, they already cover knowledge and skills for prescribing during them study and 
trained for prescribing one year after their degree.  However, motivations were raised to 
encourage other people to write discharge summaries (TTO).  Those motivations includes, 
doctors were making errors while writing TTO.  Increasing the doctors workload as they 
need to spend more time in diagnosing and treating the patients.  The cost of prescribing was 
another motivation for involving other professionals in writing discharge summaries, as those 
other health professionals cost less in terms of wages.  Tonna argued that the main driver for 
pharmacists prescribing in the UK is to make greater use of their pharmacological skills and 
specialization, which should make the prescribing system more flexible.  
 
Legally, before, pharmacists in the UK were not allowed to write discharge prescriptions, and 
doctors still had to sign and bear the responsibility for the prescription (18, 68, 69).  
However, the role of pharmacists in the UK began to change in the late 1990s in order to 
provide better services to patients, and one suggestion at that time was for pharmacists to be 
involved in transcribing discharge prescriptions (70). 
 
Subsequently, in the late 1990s, the Crown report recommended extending the authority to 
write a discharge summary to other health professionals.  She removed the legal barrier for 
pharmacists to write discharge summaries (68).  Since then, prescribing augments the GPs 
and both independent and dependent prescribers have been authorized and society now 
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accepts both pharmacist and nurses being involved in the new process of writing discharge 
summaries.   
 
The prescribing activity and the health care includes are outlined below (95): 
1 Independent prescriber (doctors, dentist, some nurse and pharmacists) 
2 Patient Group Direction (PGDs), supply medication to a group of patient e.g. 
emergency contraception for females. 
3 Supplementary prescriber (pharmacists, nurses, chiropodists/podiatrists, 
physiotherapists, optometrists and radiographers) 
4 Specific exemptions foe example (registered midwife) 
 
In order to be qualified for independent or supplementary prescribing doctors get training at 
Mandatory training and supported by their teams or pharmacists as they can prescribe from 
day one.  Both pharmacists and nurses they should attend a higher education institutions 
prepare course for prescribing for example nurses supplementary must attended at least 26 
days university tuition and 12 days of supervised practice learning in addition to self-directed 
study elements (96).  
 
3.7 Local situation of Norfolk and Norwich University Hospital (NNUH) 
Currently, at the Norfolk and Norwich University Hospital (NNUH) all admitted patients are 
given an estimated discharge date (EDD).  At discharge the unauthorised discharge 
prescription can be prepared by doctors, pharmacists or nurses, depending on the ward.  The 
unauthorised discharge summary is clinically checked by the pharmacy department and 
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authorised before the medication is dispensed and the patient discharged.  The discharge 
summary is typically sent after the patient had left the hospital, so the hospital has started to 
provide a discharge prescription (TTO) copy for the patient to hand directly to their GP.  In 
the hospital both manual and electronic systems are used to write the TTO.  However, only 
electronic TTOs are included in this study. 
 
There seems to be agreement that pharmacist must be involve in the discharge process with 
evidences strongly demonstrating that when pharmacists authorised or check doctor written 
discharge letters errors are significantly reduced.  The change in legislation following the 
Crown report has provided the opportunity for pharmacists to independently prescribe 
discharge medicines without authorisation.  The same legislation also enables nurses to 
prescribe independently.  The effect of this change on discharge medication errors is 
unknown.  Therefore the aim of this project is to determine whether this has changed the 
nature of discharge medication error in a positive or negative manner and to identify which 
factors are now predictors of discharge medication errors.  
 
3.8 Aims and objectives  
To compare the quality of discharge prescriptions (TTOs) written by doctors, nurses and 
pharmacists and adherence to audit standards. 
 
3.8.1 Objectives 
1 To determine the numbers of discrepancies in the TTOs between different transcribers 
(doctors, pharmacists and nurses) 
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2 To determine the relationship between type of transcriber and discrepancies 
3 To determine the relationship between the discrepancies and the type of medication 
prescribed 
4 To determine the relationship between the discrepancies and time that needed to 
authorised the TTOs 
5 To determine the relationship between the discrepancies and patients age/number of 
transcribed medication 
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Chapter 4 
Method 
4.1 Audit approval 
Before data collection commenced a research passport and appropriate approval for the audit 
was obtained from Research & Development department at the Norfolk and Norwich 
University Hospital Trust (NNUH).  
 
4.2 Audit standards 
100% of unauthorised discharge summaries contain no discrepancies identified by pharmacy 
when compared to authorised To Take Out (TTO) discharge summaries, medical notes and 
drug chart by researcher (see Appendix A for classification of discrepancies)  
4.3 Audit method 
The audit was carried out on three wards, A (Surgical), B (Urology/Elective cardiology) and 
C (Medicines for the Elderly) wards.  These wards were selected because discharge 
prescriptions (TTO) are written by doctors, pharmacists and nurses and they cover a wide 
range of specialities.  On these wards it is estimated that approximately 12 discharge 
summaries are transcribed by doctors, 12 by pharmacists and 3 by nurses each day.  However 
the discharge rate between these three wards was different, this discharge rate difference 
because of the patient in ward B usually admitted with pre-plan medication process and 
therefore patients stay was short and the discharge rate was high.  The length of stay is 
assumed to be shorter than Ward C because patients usually stay shorter in surgery than on 
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elderly wards thus a lower discharge rate was expected from ward C than ward B and ward 
A.  It was therefore expected that fewer TTOs would be collected from ward C which is 
medicine for elderly.    
 
Before starting the audit the researcher piloted 30 discharge summaries among them 10 were 
written by doctors, 10 by pharmacists and 10 by nurses in November 2010 to determine the 
feasibility of data collection.  After piloting the audit no changes were made to the data 
collection sheet or audit method.  The researcher undertook one week’s training to 
understand the working procedures that existed within the hospital and to identify the best 
way to find the information needed to complete the audit.  During the training the researcher 
spent time with a clinical pharmacist being shown how to identify discrepancies.  A flow 
chart of the audit design is included in Figure 2. 
4.3.1 Inclusion criteria 
The inclusion criteria of selected participants are: 
 Patient aged 18 or over years 
 Patients who have been discharged with medication 
 Wards, A (Surgical), B (Urology/Elective cardiology) and C (Medical for the Elderly) 
4.3.2 Exclusion criteria 
The exclusion criteria of selected participants are: 
 Full notes and prescription chart not available at time of discharge 
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4.4 Unauthorised TTO: Audit of medication discrepancies in unauthorised 
summaries 
This audit compares unauthorised TTOs (discharges summaries sent to pharmacy to be 
authorised) and authorised TTOs (discharge summaries ready to be sent to primary care).  All 
discrepancies will be categorised for research purposes using the modification of errors 
classification adapted on Care Home Use of Medicines Study(62) (CHUMS).  The CHUMS 
classification classified errors to omission, patient incorrect, unnecessary drug, duplication, 
allergy error/contraindication, interaction, dose/strength, and formulation error, frequency 
error, timing error, information incomplete, Medication Administration Record (MAR chart) 
transcription error, other and linked error.  Within CHUMS classification the researcher 
divided the unexplained discrepancy into omission, extra medication dose/strength, 
duplication, formulation, frequency, timing and any other discrepancy while explained 
discrepancies were classified to addition, patient refusal 
 
Unexplained discrepancies are the discrepancies that occur in TTOs without any clear reason 
for changes correctly in the available notes and are usually removed/corrected in the 
authorised TTO. These included omission (when the prescriber omitted any medication that 
already exist in patient documents), extra medication (when prescribed medication that is no 
longer used or needed), dose/strength (any discrepancy with dose or strength of the 
medication), duplication, formulation, frequency, timing and any other discrepancy that does 
not fit into one of the previous groups. Explained discrepancies are the discrepancies where 
the transcriber does know about the reason that produced the discrepancy and they include 
addition of a medication needed by the patient but not documented elsewhere and patient 
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refusal to take a medication previously prescribed but still written on the TTO. As 
unexplained discrepancies represent true discrepancies on TTOs, this study focuses on 
unexplained discrepancies during analysis.  
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Figure 2 Research Design Flow Chart 
Discharges on Ward A Ward B and C, 
 written by: Pharmacist, Nurse or Doctors 
Identified in Pharmacy 
as matching 
inclusion/exclusion 
criteria 
Compare 
Medical note  
+  
Inpatient 
prescription 
chart 
Identify and 
classify 
 
 Recording 
discrepancies 
Compare 
Data analysis 
 
Unauthorized 
TTOs  
Authorized 
TTOs by 
pharmacist 
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4.4.1 Data collection  
All original unauthorised discharge prescriptions (TTOs) were retained by the pharmacy 
department under current procedures (original unauthorised discharge prescriptions (TTOs) 
for data collection even if they are reprinted prior to dispensing due to significant changes 
during clinical check).  During data collection these were not destroyed until they have been 
reviewed by the researcher.  The researcher reviewed unauthorised discharge prescriptions 
(TTOs) between 1-3pm each week day.  Every third TTO from each study ward, stratified by 
transcriber and meeting the inclusion criteria was selected for audit inclusion.  For each 
included TTO, copies of the inpatient prescription chart and the last five days of their 
medical notes were taken and anonymised in addition to a copy of their authorised discharge 
summary.  Dates of unauthorised discharge prescription (TTO) were extracted from the 
hospital’s audit log held on the hospital’s electronic records. 
 
The researcher created an audit number for each patient, and for all included patients the 
following information obtained from the discharge summary, medical notes and inpatient 
prescription chart: 
 Audit Number  
 Time and date of admission  
 Time and date of estimated discharge (EDD) 
 Date of discharge 
 Patient’s age 
 Patient’s gender 
 Number of regular medications 
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 Number of PRN medications 
 Details of medicines prescribed 
 Grade/Band of TTO transcriber (Accurate details of these were not available at the 
time of analysis) 
 
This information was collected using a data collection sheet (Appendix B).  The patient’s 
hospital number and audit number were recorded on a separate encryption form (Appendix 
C) which was stored in the pharmacy department in the rare event that notes need to be 
referred back to at a later date.  Only anonymised data on the data collection form left the 
hospital.  
 
4.5 Sample size estimation  
To detect a 20% of differences in errors based on assumption that the error rate in one group 
is 10% and the other is 30%; then data from 59 patients is required in each group to detect 
the differences with 80% power at 5% significant level.  
 
4.6 Patient confidentiality and data storage 
All patients were coded with an audit number using the encryption form (Appendix C) which 
links to patient identifiable information; this was stored in the pharmacy department under 
normal storage procedures.  All documents used in this audit (unauthorized and authorized 
discharge prescriptions (TTO), medical notes, inpatient prescription chart) and any copies of 
them were stored in the hospital.  Only encrypted data on the data collection sheet was taken 
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away for analysis.  Once the audit is completed and data verified all copied data will be 
placed in the pharmacy department confidential waste. 
 
4.7 Data analysis 
Statistical analysis was carried out using SPSS 18.  Patient demographics were described 
using descriptive data analysis. 
 
Discrepancies identified in unauthorised TTO were analysed using, Chi-square analysis to 
compare the number and type of errors between each healthcare professional, ward location, 
patient gender and BNF chapters in the audit.  Mann-Whitney U analysis was used for 
discrepancies according to patient’s age and length of stay.  
 
Logistic regression was used to identify predictors of unexplained discrepancies using the 
dichotomised dependant variable (discrepancies).  All potential predictors were considered, 
scatter plots of ordinal data were used to identify if there was a linear relationship, in this 
instance all factors were entered in to the model.  If there was no clear linear relationship 
variables were dichotomised at the point where the relationship changed.  Within each level 
of factors the one with the lowest percentage of discrepancies was removed and used as a 
comparator.  The final stage of backwards conditional logistic regression was reported as this 
is exploratory analysis to identify potential predictors. 
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Chapter 5 
Results 
5.1 Patients demography 
The wards included in the audit A (surgical), B (urology/elective cardiology) and C 
(medicine for elderly) produced 624 TTOs.  From these 227 TTOs were included in the 
audit, 12 were excluded because of missing information, the drug chart was missing from 3 
patients and medical notes were missing from 9 patients. Therefore 215 discharge summaries 
which matched the inclusion/exclusion criteria were included in this audit. 
 
Table 5.1 presents the demographic data for audit patients. It can be seen that there are 
differences between doctors, pharmacists and nurses in transcribing activity.  On Ward B 
(urology/elective cardiology) pharmacists transcribed medication for more patients (93%) 
than doctors and nurses.  Nurses transcribed for the most patients on ward A (surgical) 
(94%). 
 
Regarding gender, in general there are more male patients seen in the audit than female 
patients. Pharmacists transcribed TTO’s for more male patients than doctors and nurses, 
while doctors prescribed more TTO’s for female patients than nurses and pharmacists. There 
is no difference in patient age between transcribers with the median age 73 years. Nurses 
transcribe more TTO’s for patient with a longer length of stay.  The longest time between 
writing the unauthorised TTO and the authorised one is with nurse transcribers, compared to  
pharmacists TTO which are automatically authorised at the time of transcribing. 
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Table 5.1 Comparison of discharge summaries by transcriber 
Characteristics 
Transcriber 
Pharmacist 
(n=85) 
Doctor 
(n=81) 
Nurse 
(n=49) 
Total 
(n=215) 
Ward (N (%)) 
Ward A 
Ward B 
Ward C 
 
3 (3.7) 
78 (66.7) 
3 (17.6) 
 
32 (39.5) 
37 (31.6) 
13(31.6) 
 
46 (56.8) 
2 (1.7) 
1(11.8) 
 
81  
117  
17 
Female Gender (N(%)) 19 (22.6) 31 (37.8) 26 (53.1) 76 (35.3) 
Age (median(IQ)) 
70.0 
(51.0-80.0) 
75.0 
(64.8-84.0) 
74.0 
(60.0-80.0) 
73.0 
(61.0-82.0) 
Total Number of prescribed 
medication 
473 535 349 1357 
Median of medication (IQ) 5.0 (3.0-7.0) 6.0 (4.0-9.0) 7.0 (5.0-9.0) 6 (4.0-8.5) 
TTOs with at least one 
discrepancy (N(%)) 
36 (42.9) 38 (47.0) 31 (63.3) 105 (48.8) 
TTOs with at least one 
unexplained discrepancy 
(N(%)) 
11 (12.9) 24 (29.6) 20 (40.8) 55 (25.6) 
Length of stay (day) 
(median(IQ)) 
2.0 (1.2-4.7) 4.5 (2.0-9.0) 7.0 (3.0-12.5) 4.0 (2.0-8.0) 
Time between writing un-
authorised and authorised 
TTO (hours) median (IQ)
 
0.0 (0.0-0.0)
* 
0.8 (0.3-3.1) 1.7 (0.7-5.0) 50 (25.0-75.0) 
*
Median (IQ) pharmacists write authorised and unauthorised TTO on the same time 
 
Ward A is a surgical ward, patients tend to be abdominal aortic aneurysm (AAA), 
amputations, carotid endarterectomy (CEA) and endovascular abdominal aortic repair 
(EVAR) and common medicines used in this ward were Aspirin, Statins and antihypertensive 
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medicines.  Ward B is a urology and most of the patients are admitted due to Trans urethral 
resection prostate (TURP), Trans urethral resection bladder tumour (TURBT), ureteroscopy 
and nephrectomy-kidney removal.  In such ward the transcriber usually prescribes analgesic 
(paracetamol, codeine and oramorph), Dalteparin prophylaxis and antibiotic such as 
(Gentamicin and Co-amoxiclav).  However ward C is medicine for the Elderly and the most 
common admissions were for Pneumonia, Urinary tract infection (UTI) and falls cases and 
the medication patients received was mostly Aspirin, Furosemide and Adcal D3. 
 
The comparison of the medication types transcribed according to the British National 
Formulary (BNF) chapters between the transcribers is shown in Table 5.2.  The most 
commonly transcribed medication comes from the central nervous system chapter (30%).  
The next most commonly transcribed medication was for the cardiovascular system (26%), 
where according to the table doctors write more medication from the cardiovascular chapter 
than the rest of the BNF chapters. 
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Table 5.2 Comparison of medication types (BNF chapter) Used by each transcribers 
BNF chapter 
(Type of medication) 
Transcriber 
Pharmacist 
(n=473) 
Doctor 
(n=535) 
Nurse 
(n=349) 
Total 
(n=1357) 
BNF chapter of discharge medication 
(N(%))
a 
 
Gastro-intestinal system
 
 
Cardiovascular system
 
 
Respiratory system
 
 
Central nervous system
 
 
Infections 
 Endocrine system
 
 
Obstetrics, gynaecology
b
 
 
 
Nutrition and blood
 
 
Musculoskeletal
c 
 
Other 
d 
 
 
50 (10.6) 
91 (19.2) 
33 (7.0) 
161 (34.0) 
35 (7.4) 
31 (6.6) 
18 (3.8) 
12 (2.5) 
21 (4.4) 
21 (4.4) 
 
 
69 (12.9) 
168 (31.4) 
26 (4.9) 
156 (29.2) 
26 (4.9) 
39 (7.3) 
12 (2.2) 
16 (3.0) 
7 (1.3) 
16 (3.0) 
 
 
47 (13.5) 
89 (25.5) 
27 (7.7) 
93 (26.6) 
23 (6.6) 
25 (7.2) 
5 (1.4) 
14 (4.0) 
9 (2.6) 
17 (4.8) 
 
 
166 (12.2) 
348 (25.6) 
89 (6.3) 
410 (30.2) 
84 (6.2) 
95 (7.0) 
35 (2.6) 
42 (3.1) 
37 (2.7) 
54 (4.0) 
a
Only illustrated if prescribed more than 5% of the time,
 b
and urinary-tract disorders, 
d
e.g. Malignant disease 
and immunosuppression, musculoskeletal and joint diseases, eye, ear, nose, and oropharynx, skin, anaesthesia, 
c
and joint diseases. 
5.2 Transcriber 
The wards in the study were surgical, urology/elective cardiology and medicine for elderly, 
all transcribers were trained in the same way pharmacist did prepare course, training and 
accredited to become a prescriber, doctors had the usual rotation and training to prescribe 
from day one and nurses had done their training and tuition to be a qualified independent 
prescriber 
5.2.1 TTOs 
Table 5.3 illustrates discrepancies according to type of prescriber based on total number of 
transcribed medication.  From the table it is clear that pharmacists have fewer discrepancies 
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than doctors and nurses.  The most common unexplained discrepancy is omission. The most 
common explained discrepancy was when a patient refuses to take medication but it was still 
transcribed in the TTO. 
 
Table 5.3 Comparison of discrepancies to number of medication (Un-authorised TTOs) 
Type of discrepancies Total number of medication/professional P-
value*
 
Pharmacist 
(n=473) 
Doctor 
(n=535) 
Nurse 
(n=349) 
Total 
(n=1357) 
Unexplained discrepancies (N(%)) 
 Omission 
 Extra medicine 
 Dose/strength (N(%)) 
 Other
c
 
 
8 (1.7) 
5 (1.1) 
1 (0.2) 
1 (0.2) 
 
17 (3.2) 
11 (2.1) 
5 (0.9) 
12 (2.1) 
 
16 (4.6) 
7 (2.0) 
1 (0.3) 
6 (1.8) 
 
41(3.0) 
23 (1.7) 
7 (0.5) 
19 (1.4) 
 
0.055 
0.411 
0.073 
0.006 
Total no. of unexplained (N(%)) 15 (3.2) 45 (8.4) 30 (8.6) 90 (6.5) 0.001 
Explained discrepancies (N(%)) 
 Addition  
 Patient refusal 
 
3 (0.6) 
27 (5.7) 
 
12 (2.2) 
29 (5.4) 
 
0 (0.0) 
26 (7.4) 
 
15 (1.1) 
82 (6.0) 
 
0.004 
0.433 
Total no. of discrepancies in 
unauthorised TTO (N(%)) 
45 (9.5) 86 (16.1) 56 (16.0) 187 (13.8) 0.004 
c
E.g. Duplication, formulation, frequency, timing and any other discrepancy, *Chi-square test 
 
Table 5.4 compares discrepancies according to the type of prescriber based on the total 
number of discrepancies made by each transcriber.  There are 43 patients that had more than 
one error in their TTO.  It is clear that pharmacists have fewer discrepancies than doctors and 
nurses and doctors made the most unexplained discrepancies.  Omission was the most 
common unexplained discrepancy and patient refusal the most common explained 
discrepancy. 
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Table 5.4 Comparison of discrepancies to transcriber (Un-authorised TTOs) 
Type of discrepancies Total number of discrepancies made by each 
professional 
Type of error Pharmacist 
(n=45) 
Doctor 
(n=86) 
Nurse 
(n=56) 
Total 
(n=187) 
P-value* 
Unexplained discrepancies (N(%)) 
 Omission 
 Extra medicine 
 Dose/strength (N(%)) 
 Other
a
 
 
8 (17.8) 
5 (11.1) 
1 (2.2) 
1 (2.2) 
 
17 (19.8) 
11 (12.8) 
5 (5.8) 
12 (14.0) 
 
16 (28.6) 
7 (12.5) 
1 (1.8) 
6 (10.7) 
 
41 (22.0) 
23 (12.3) 
7 (3.7) 
19 (10.2) 
 
0.159 
0.585 
0.023 
0.021 
Total no. of unexplained 
discrepancies (N(%)) 
15 (33.3) 45 (52.3) 30 (53.6) 90 (48.1) 0 001 
Explained discrepancies (N(%)) 
 Addition  
 Patient refusal  
 
3 (6.7) 
27 (60.0) 
 
12 (14.0) 
29 (33.7) 
 
0 (00.0) 
26 (46.4) 
 
15 (8.0) 
82 (43.9) 
 
0.349 
0.339 
a
E.g. Duplication, formulation, frequency, timing and any other discrepancy, *Chi-square test
 
5.2.2 Wards 
Table 5.5 compares discrepancies according to the wards based on total number of 
medication transcribed in each ward.  As shown in the table there are differences between the 
wards in number of medication that was prescribed ward A (surgical) has more discrepancies 
than ward B (urology/elective cardiology) and ward C (medicine for elderly).  Across the 
three wards the most common unexplained discrepancy was omission. The most common 
explained discrepancy was when a patient refused to take medication but it was still 
transcribed in the TTO. 
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Table 5.5 Comparison of discrepancies to the wards (Un-authorised TT) 
Type of discrepancies Total number of medication transcribed in each ward 
Ward A 
(n=602) 
Ward B 
(n=645) 
Ward C 
(n=110) 
Total 
(n=1357) 
P-value
* 
Unexplained discrepancies (N(%)) 
 Omission 
 Extra medicine 
 Other
a
 
 
28 (4.7) 
12 (2.0) 
18 (3.0) 
 
12 (1.9) 
7 (1.1) 
7 (1.1) 
 
1 (1.0) 
4 (3.6) 
1 (1.0) 
 
41 (3.0) 
23 (1.6) 
26 (2.0) 
 
0.006 
0.119 
0.036 
Total no. of unexplained 
discrepancies (N(%)) 
 
58 (9.6) 
 
26 (4.0) 
 
6 (5.4) 
 
90 (6.6) 
 
<0.001 
Explained discrepancies (N(%)) 
 Addition 
 Patient refusal 
 
7 (1.2) 
37 (6.1) 
 
8 (1.2) 
43 (6.7) 
 
0 (00.00) 
2 (1.8) 
 
15 (1.1) 
82 (6.0) 
 
0.508 
0.141 
Total no. of discrepancies in 
unauthorised TTO (N(%)) 
102 (17.9) 77 (12.0) 8 (7.3) 187 (13.8) 0.004 
a
E.g. Duplication, dose/strength formulation, frequency, timing and any other discrepancy, *Chi-square test 
 
5.2.3 Gender 
Table 5.6 illustrates the type of discrepancies in comparison to medication used by gender.  It 
is shown that there are differences in total number of unexplained discrepancies according to 
gender.  Omission was the most common discrepancy and there was a greater proportion in 
discrepancies in female campier to male.
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Table 5.6 Comparison of discrepancies to gender (Un-authorised TTOs) 
Types of discrepancies Total number of medication implicated with 
gender 
Male 
(n=879) 
Female 
(n=478) 
Total 
(n=1357) 
P-value* 
Unexplained discrepancies (N(%)) 
 Omission 
 Extra medicine 
 Other
a
 
 
22 (2.5) 
11 (1.3) 
14 (1.6) 
 
19 (4.0) 
12 (2.5) 
12 (2.5) 
 
41 (3.0) 
23 (1.7) 
26 (2.0) 
 
0.006 
0.119 
0.036 
Total no. of unexplained discrepancies (N(%)) 47 (5.3) 43 (9.0) 90 (6.6) <0.001 
Explained discrepancies (N(%)) 
 Addition 
 Patient refusal 
 
8 (0.9) 
58 (6.6) 
 
7 (1.5) 
24 (5.0) 
 
15 (1.1) 
82 (6.0) 
 
0.508 
0.141 
Total no. of discrepancies in unauthorised 
TTO (N(%)) 
113 (13.0) 74 (15.5) 187 (13.8) 0.004 
a
Only illustrated if discrepancy frequency lees than 5 of one of the following types (duplication, dose/strength 
formulation, frequency, timing and any other discrepancy), *Chi-square test 
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5.2.4 Type of medication (BNF chapter) 
 
Table 5.7 compares the type of discrepancies according to medication used of each BNF 
chapter. As shown from the table there are a difference between discrepancy frequencies in 
comparison to BNF chapter with cardiology medicines having the highest percentage of 
unexplained discrepancies and most of these were omissions.  Central nervous system 
medication is the most common explained refused of medication. 
 
Table 5.7 Comparison of discrepancies to type of medication (Un-authorised TTOs) 
Types of discrepancies Total number of medication prescribed from each 
medication types (BNF chapter) 
P-value
* 
Gastro
1
 
(n=166) 
Cardio
2
 
(n=348) 
3
Central- 
(n=410) 
Other
a
 
(n=433) 
Total 
(N=1357) 
Unexplained error (N(%)) 
 Omission 
 Extra medicine 
 Other
a
 
 
3 (1.8) 
3 (1.8) 
4 (2.4) 
 
13 (3.7) 
6 (1.7) 
7(2.0) 
 
14 (3.4) 
6 (1.5) 
8 (2.0) 
 
11 (2.5) 
8 (1.8) 
7 (1.6) 
 
41 (3.0) 
23 (1.7) 
26 (2.0) 
 
0.055 
0.411 
0.006 
Total no. of unexplained 
discrepancies (N(%)) 
10 (6.0) 26 (7.5) 28 (6.8) 26 (6.0) 90 (6.6) 0.001 
Explained discrepancies 
(N(%)) 
 Addition 
 Patient refusal 
 
 
4 (14.3) 
14 (8.4) 
 
 
4 (1.1) 
10 (3.0) 
 
 
3 (0.7) 
41(10.0) 
 
 
4 (0.9) 
17 (3.9) 
 
 
15 (1.1) 
82 (6.0) 
 
 
0.004 
0.433 
Total no. of discrepancies 
in unauthorised TTO 
(N(%)) 
28 (17.0) 40 (11.5) 72 (17.6) 47 (11.0) 187 (13.8) 0.004 
1
Gastro-intestinal system, 
2
cardio vascular system, 
3
central nervous system,
 a
e.g. infections, endocrine 
system, respiratory system, obstetrics, gynaecology, and urinary, nutrition and blood, musculoskeletal and 
joint diseases, ear, nose, and oropharynx and skin, 
a
e.g.
 
duplication, dose/strength, formulation, frequency, 
timing error and any other discrepancy, *Chi-squared test 
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5.2.5 Age and length of stay 
 
Table 5.8 compares type of discrepancies to patient’s median age  and it is clear that there is 
no difference in discrepancy frequency in comparison to patient ages.  
 
Table 5.8 Comparison of discrepancies to age (Un-authorised TTOs) 
Types of discrepancies Age (median(IQR)) P-value
* 
 Discrepancy No discrepancy  
Unexplained discrepancies 
 Omission 
 Extra medicine 
 Dose/strength discrepancies 
 Other
a
 
 
72.0(62.0-85.0) 
78.0(68.0-84.5) 
75.0(60.0-81.0 
74.0(59.5.0-79.5)) 
 
74.0(58.0-81.0) 
73.0(60.0-81.5) 
73.0(61.0-82.0) 
73.0(61.0-82.5) 
 
0.533 
0.240 
0.776 
0.865 
Explained discrepancies 
 Addition 
 Patient refusal 
 
67.5(55.0-81.5) 
73.5(62.5-81.0) 
 
74.0(61.0-82.0) 
73.0(58.0-82.5) 
 
0.886 
0.912 
a
E.g.
 
Duplication, formulation, frequency, timing and any other discrepancy, 
*
Mann-Whitney test 
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Table 5.9 compares the type of discrepancies to the patient’s median length of stay.  The 
table shows a difference in discrepancy number in comparison to patient stay.  Patient with 
long stay median (IQ) 9.0 (5.5-18.5) days have more dose and strength discrepancies than 
those patient who stay for a short time with median (IQ) 3.5 (2.0-8.0) days in hospital. 
 
Table 5.9 Comparison of discrepancies to patient length of stay (Un-authorised TTOs) 
Types of discrepancies Length of stay/days (median(IQR)) P-value
* 
 discrepancies No discrepancies  
Unexplained discrepancies 
 Omission 
 Extra medicine 
 Dose/strength error 
 Other
a
 
 
5.0(2.0-12.0) 
5.5(2.5-10.0) 
9.0(5.5-18.5) 
5.0(4.0-11.5) 
 
3.5(2.0-7.0) 
3.0(2.0-8.0) 
3.5(2.0-8.0) 
3.0(2.0-8.0) 
 
0.173 
0.181 
0.032 
0.059 
Explained discrepancies 
 Addition 
 Patient refusal 
 
4.5(3.0-6.0) 
4.0(2.0-8.5) 
 
4.0(2.0-8.0) 
3.0(2.0-8.0) 
 
0.593 
0.076 
a
E.g.
 
Duplication, formulation, frequency, timing and any other discrepancy, 
*
Mann-Whitney test 
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5.3 Regression analysis 
The logistic regression binary entered method was used to analyse the data related to 
unexplained discrepancies and the results were extracted from the Backward Conditional 
summary. 
5.3.1 Factors predicting unexplained discrepancies  
Table 5.10 illustrate the factors which may predict unexplained discrepancies.  The 
unexplained discrepancies were the dependent variable.  In this study there were many 
independent variables that may have a relation to the unexplained discrepancies.  These 
variables include: gender, age, patient length of stay, the transcriber, wards, time difference 
between writing the un-authorised TTO and the authorised TTO and the number of 
medication that prescribed for each patient.   
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Table 5.10 Factors which may predict unexplained discrepancies 
Factors Total No. 
of patients 
Patient had at least 
one unexplained 
discrepancy 
% of patients had at least one 
unexplained discrepancies  
Gender 
 Male 
 Female 
 
139 
76 
 
31 
24 
 
22.3% 
31.6% 
Age 
 ≤ 40 
 41-49 
 50-60 
 61-70 
 71-80 
 ≥ 80 
 
19 
15 
19 
38 
63 
61 
 
4 
1 
7 
9 
17 
17 
 
21.0% 
6.7% 
36.8% 
23.7% 
27.0% 
27.9% 
Length of stay/days 
 1-3 
 4-10 
 11-30 
 ≥ 31 
 
105 
70 
35 
5 
 
17 
21 
14 
3 
 
16.2% 
30.0% 
40.0% 
60.0% 
Transcriber 
 Doctor  
 Nurse 
 Pharmacists 
 
81 
49 
84 
 
24 
20 
11 
 
29.6% 
40.8% 
13.1% 
Wards 
 Ward A 
 Ward B 
 Ward C 
 
81 
117 
17 
 
31 
19 
5 
 
38.3% 
16.2% 
29.4% 
Time difference 
between writing 
TTOs/hours 
 0 hr 
 0.1-1 hr 
 1.1-3 hr 
 3.1-10 hr 
 ≥ 10 hr 
 
 
 
75 
65 
30 
13 
32 
 
 
 
3 
18 
11 
8 
15 
 
 
 
4.0% 
27.7% 
36.7% 
61.5% 
46.9% 
No of 
medication/patient 
 ≤ 3 
 4-10 
 11-15 
 ≥ 16 
 
 
48 
143 
21 
3 
 
 
6 
37 
10 
2 
 
 
12.5% 
25.9% 
47.6% 
66.7% 
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5.3.2 Grouping and comparator 
Within each factor the researcher determined which variable should be entered into a 
regression model and within each level of factors the one with the lowest percentage with 
discrepancies were removed and used as comparator. 
 
5.3.2.1 Gender  
For gender the percentage of discrepancies with female patients was higher than male 
patients showing that the female patients are more likely to have unexplained discrepancies 
than male patients.  Therefore gender was selected as independent factor to enter into 
regression analysis. 
 
5.3.2.2 Age 
Among 55 TTOs have at least one unexplained discrepancy, the total number of TTOs for 
patients who under 50 year was 34 and five of these have at least one unexplained 
discrepancy (15%).  However, the total number of TTOs for patients who ≥ 50 year was 181 
and 50 of these have at least one unexplained discrepancy (28%). Consequently, it is clear 
that there was a difference in the percentage of unexplained discrepancies between patients 
under 50 year and patients over 50 year.  Therefore age was classified as a dichotomous 
variable.  
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5.3.2.3 Length of stay 
For length of stay there is a linear relationship with percentage of unexplained discrepancies 
and therefore they were all entered in the regression analysis. 
 
5.3.2.4 Transcriber 
Previous research has suggested that pharmacists made less errors than doctors while writing 
discharge prescription (TTO) (83).  In addition there was a different in the percentage of 
unexplained discrepancies between the prescriber.  Therefore two prescriber (doctor and 
nurses) were used as variables in the logistic regression. 
 
5.3.2.5 Wards 
The percentage of unexplained discrepancies is different between wards.  Therefore the type 
of the ward was elected as a variable to be entered into the regression analysis. 
 
5.3.2.6 Time difference between writing un-authorised TTO and authorised TTO 
As the gap time between writing the un-authorised TTO and the authorised TTO increases, 
the number of unexplained discrepancies also increased.  The initial descriptive analysis 
Table 5.10 demonstrate a clear variation in the percentage of unexplained discrepancies 
between less than 3 hr (19%) and over 3.1 hr (15%) time gap.  Therefore to clarify this 
relationship the time difference classified as two variables to enter into regression analysis. 
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5.3.2.7 Number of medication  
The number of medication prescribed has a linear relationship with the percentage of 
unexplained discrepancies.  Consequently, the number of medication was elected as a 
variable to enter to the regression method.
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Table 5-11 reveal the group of variables that were entered into the regression analysis, all 
variables have value of 0 or 1 except gender which is had value 1 (male) and 2 (female).  It is 
clear that when patient stay at hospital longer the probability of unexplained discrepancies to 
be appeared increased.  From odds ratio it is clear that doctors and nurse likelihood to make 
unexplained discrepancies.  When the time gap is increased between writing the un-
authorised TTO and the authorised TTO the percentage of unexplained discrepancies 
increased and this was similar when there was an increase in the number of medication 
prescribed for the patient. 
 
Table 5.11 Variables to be entered to regression analysis 
Variables P-value Exp (B) 
Gender 0.607 1.219 
Age  
 ≥50 
 
0.525 
 
1.435 
Length of stay/days  
 4-10 
 11-30 
 ≥ 31 
 
0.694 
0.202 
0.151 
 
1.187 
1.970 
4.389 
Transcriber 
 Doctors 
 Nurses 
 
0.139 
0.101 
 
2.124 
2.973 
Wards 
 Ward A 
 Ward C 
 
0.792 
0.744 
 
0.869 
0.788 
Times difference between writing 
TTOs/hr 
 ≥ 3.1hr 
 
 
0.005 
 
 
3.177 
No. of medication 
 4-10 
 11-15 
 ≥ 16 
 
0.469 
0.097 
0.160 
 
1.459 
3.125 
7.945 
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The binary dependent variable was the presence of at least one unexplained discrepancy or 
no discrepancy at all.  Transcriber, times difference between writing the un-authorised TTO 
and authorised TTO and the number of medication (11-15 medicines/patient) were the 
predictors introduced within the model.  Table 5.12 described the codes used on the analysis. 
 
Table 5.12 Categorical codes employed in logistic regression model predicting 
unxplaned discrepencies 
Category  Code 
Transcriber 
 Doctor 
 Non doctor 
 Nurse 
 Non nurse 
 
1 
0 
1 
0 
Time  
 Time difference between writing TTOs/hr ≥ 3.1hr 
 Time deference between writing TTOs/hr < 3.1hr  
 
1 
0 
Medication 
 Between 11-15 medication/patient  
 Other number of medication  
 
 
1 
0 
.
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Table 5.13 Summary of the final step in the logistic regression analysis.  Three significant 
predictors were identified.  The model explains 21% of the variance in the model to predict 
unexplained discrepancies in TTOs. 
 
Table 5.13 Summary for logistic regression model to identify predictors of reporting 
unexplained discrepancies 
Variables Beta (SE) Wald P-value 
Constant -2.29 (0.36) 41.67 <0.001 
Age 50-60 0.97 (0.55) 3.2 0.075 
Prescriber 
 Doctors 
 Nurses 
 
0.82 (0.43) 
1.23 (0.46) 
 
3.70 
7.30 
 
0.054 
0.007 
Times difference between writing TTOs/hr 
 ≥ 3.1 hr 
 
1.36 (0.38) 
 
12.64 
 
<0.001 
No. of medication 
 11-15 
 
0.91 (0.51) 
 
3.12 
 
0.076 
Note R
2
=0.10 (Hosmer & Lemeshow), 0.207 (Nagelkerke) 
 
Table 5.14 Adjusted odds ratios for predictors of reporting unexplained discrepancies 
Variables 95% Confidence interval for exp b 
 Lower Exp b Upper 
Age 50-60 0.90 2.65 7.75 
Prescriber 
 Doctors 
 Nurses 
 
0.98 
1.40 
 
2.26 
3.45 
 
5.21 
8.46 
Times difference between writing TTOs/hr 
 ≥ 3.1 hr 
 
1.84 
 
3.88 
 
8.20 
No. of medication 
 11-15 
 
0.91 
 
2.47 
 
6.73 
 
Doctors and nurses are likely to makes unexplained discrepancies OR, 95% CI (2.26, [0.98-
5.21]) and OR, 95% CI (3.45, [1.40-8.46]), respectively in comparison to pharmacists which 
is appeared statistically significant (P-value < 0.05).  A time gap of more than 3.1 hr between 
writing the un-authorised and authorised TTO was appeared statistically significant to 
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increase the likelihood of unexplained discrepancies OR 3.88, 95% CI [1.84-8.20].  Patients 
who are prescribed > 11 medicines were more likely to have unexplained discrepancies, 
beyond 15 medicines, there is still an increase but less pronounced change, which was not 
statistically significant. 
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Chapter 6 
Discussion 
6.1 Summary of main findings 
This was one of the first studies to investigate the discrepancies between hospital to take out 
prescriptions (TTOs) transcribed by different healthcare professionals in a UK hospital.  The 
discrepancies were identified by an independent researcher who reviewed the original 
transcribed TTOs, known as the unauthorised TTO, which is the prescription that 
traditionally is checked and dispensed by pharmacy.  The researcher used the final checked 
prescription, authorised TTO, drug chart and medical notes to identify discrepancies.  
Therefore the discrepancies identified are potential discrepancies and do not represent the 
final prescription that was actually given to the patient.    
 
6.2 Selection of unauthorised TTO 
The study was conducted as an audit and therefore data was collected retrospectively from 
TTOs written by different healthcare professionals and therefore it is more difficult to clarify 
the information.  When designing the audit, consideration was given to try and minimise the 
variation in patient demographics in TTOs transcribed by different healthcare professionals. 
Ideally one ward would have been identified where TTOs are written by doctors, nurses and 
pharmacists because this would minimize variation between the patients. In this instance 
errors could then more clearly be attributed to the different professionals; unfortunately this 
was not possible.  While doctors transcribe TTOs in all clinical areas, the situation was not 
the same for pharmacists and nurses.  At the NNUH the pharmacists transcribe TTOs in 
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different wards in the hospital, mainly to improve turnaround times for discharge of patients. 
The focus has been ward areas where this has historically been problematic at the hospital, 
mainly urology wards and medicine for the elderly wards.  Nurses only transcribe TTOs 
where there are nurse prescriber which is mainly on general surgical wards.  Therefore, the 
only way to include a significant number of TTOs from each transcriber was to include 
urology/elective cardiology, a general surgical ward and medicine for the elderly. 
 
In designing the study, attempts were made to maximise variation in the sample included, 
therefore all TTOs from the study wards were reviewed and every third TTO from each 
transcriber type (doctor, pharmacist or nurse) were selected.  This was to minimise the 
chance of large number of TTOs written by the same transcriber at the same time being 
included.  Therefore the types of discrepancy should vary and any effects of a transcriber 
having a ‘bad day’ minimised.   
 
A sample calculation found that 59 TTOs from each transcriber was required to detect a 20% 
difference in discrepancies from a baseline of 10% discrepancies with one transcriber to 30% 
in another transcriber.  In the available time, obtaining 59 TTOs from each transcriber group 
was thought to be feasible based on the predicted number TTOs to be written by each. 
However, nurses wrote less TTOs that could be included in the audit and so the required 
sample size for nurses was not achieved.  The TTO’s for pharmacists and doctors exceed the 
target for 59 as the audit was still running to try to achieve the sample size for nurses.  Due to 
time constraints the audit was stopped with a total of 215 TTOs included, therefore the study 
was underpowered with respect to identify differences in discrepancies between transcribers.  
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When comparing this study to previous study results it appears this study is underpowered, 
however previous studies have included administration and monitoring errors in their results.  
This study shows only prescribing errors, this may explain why this study provides less 
discrepancies and therefore may not be underpowered. 
 
Despite efforts to minimise variation in patient demographics this audit included significant 
intra and inter transcriber variation.  While it is accepted that pharmacists are recognised as 
medicine experts (97) and their standard training, skills and knowledge may make them 
suitable for identifying discrepancies, however they do not usually follow a patient 
throughout their care and may not be completely familiar with their case when transcribing 
the TTO and consequently will mainly rely on the drug chart and medical notes.  Nurses are 
trained to provide nursing care which traditionally focuses on assisting individuals with 
recovery to health (or peaceful death), while they are familiar with the patient they may be 
less familiar with medication.  Doctors have the appropriate knowledge and training to 
diagnose and treat the patient.  They are much closer to the patient and know the patients 
case more in depth than pharmacists, however they have less knowledge about medicines.  
 
The traditional system of prescribing in hospital means that nurses and doctors look after the 
patients and write the TTO which then gets checked and authorised by the pharmacist (figure 
3).  However this system can cause a number of delays while the pharmacy department check 
the prescriptions and amend any errors, which decreases the efficiency of discharge.  
Allowing pharmacists to transcribe is believed to make this more efficient (see figure 3).  
However it is not known if using pharmacist transcribers, practitioners more distant from the 
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patients daily care, will affect discrepancies and hence the efficiency and safety of the 
discharge procedure.  Overall this audit suggests that pharmacists make fewer discrepancies 
than other transcribers and consequently the newer system should be more efficient and safer.  
However this audit does not identify errors in authorised TTOs and therefore it is possible 
that when a pharmacist transcribed TTO is checked by the doctor and dispensed by the 
pharmacy department less errors are identified at this stage as these practitioners assume it is 
correct (pharmacists are usually the professional checking TTOs).  While knowing which 
practitioners are more prone to discrepancies is important it is far more important to identify 
the best way for all healthcare professionals to work together to reduce errors.  
 
Figure 3 Old system and new approach in writing the TTO 
 
Patient 
Pharmacist 
 
Pharmacist 
 
Patient 
 
Pharmacist 
Patient 
Nurse  Doctor 
Patient 
Traditional system New system 
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Although not formally recorded this audit sample also included pharmacists with significant 
variation in experience, doctors from diverse teams, specialities, grade and experience, but 
only included a very small number of nurses. While the majority of doctors included were 
junior doctors, it is not appropriate to generalise these results across a whole profession.  
Low knowledge, experience and inadequate training for medical staff can produce 
discrepancies.  For example, MacAulay et al. reported that the junior doctors make more 
errors when writing discharge summaries (17%) than consultants (2%) (65, 66).   
 
As well as intra-transcriber and inter-transcriber differences, there were differences in the 
patient demographics that the three groups of transcriber wrote TTOs for.  Participants were 
from different ward which are different specialities, therefore, suffering different conditions 
and receiving different types and number of medications and had varying lengths of stay.  
Consequently there was not equal spread of transcriber over the different patient types and it 
is hard to compare between these groups (14, 98). 
 
6.3 Discrepancies 
Medication errors are commonly found in discharge prescriptions (called now To Take Out 
(TTOs)).  This type of error is one of the major reasons for mortality worldwide, and is the 
most common type of medical error, which undoubtedly affects the quality of care (99).  This 
audit identified two types of discrepancies, explained and unexplained.  The total percentage 
of discrepancies was 49% of these discrepancies 23 % were explained and 27% were 
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unexplained.  All of the unexplained discrepancies identified in this audit were corrected 
before medication was dispensed to the patients. 
 
When the number of discrepancies in the TTOs increases the chance that errors can reach the 
patient increases (100).  A high rate of discrepancies in TTOs has significant implications for 
the patient and the hospital.  For the patient’s, medication errors may cause harm or even 
death (101), though often this is not the case.  The patient’s time is also wasted while waiting 
for TTO, if a number of discrepancies have to be checked and corrected this will also 
increases costs for the hospital (discharge delays) (76, 102, 103). 
 
Delays in obtaining an authorised TTO may delay the release of beds which are required for 
new patients (104), thereby hindering hospital admission efficiency (105).  Increase the 
length of stay (74) or even readmission to hospital due to errors which can also impact on 
bed availability.  All of this also comes at a financial cost for the hospital (103), as well as 
being costly in terms of rankings and reputation which could have subsequent effects on the 
hospital. 
 
Hospitals have tried a variety of approaches to reduce errors such as converting to electronic 
systems for admission, discharge, reporting patient cases, writing TTOs and introducing 
electronic transcribing (48).  This study audited an electronic discharge prescription system, 
these do not automatically decrease discrepancies but merely change the type of 
discrepancies made from previous handwritten systems.  Although that the electronic system 
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is facilitating the extraction of patient and medication information, however the user (e.g. 
training), computer and transcription factors still contributes to errors (19, 26). 
 
This study identified a significant number of discrepancies in unauthorised TTOs, however 
the significance of the discrepancies was not reported.  The CHUMS classification system 
used in this audit does not consider the significance of discrepancies.  For example, an 
omission of digoxin for heart failure is more significant than an omission of paracetamol for 
a headache. Having neither a clinical pharmacist nor a computer system available, rating the 
significance of the discrepancies seen in the audit was not possible. 
 
In comparison to the CHUMS study which included 256 patients in care home and recorded 
153 discrepancies.  The CHUMS study used three techniques to identify discrepancies; 
observation, interview and checking the discrepancies between patients’ records.  However, 
in this study the researcher checked the unauthorised TTOs against authorised TTOs, drug 
charts and medical notes.  This study also looked for discrepancies that occurred while 
transcribing TTOs, while the CHUMS study errors were noted in the wider process and 
errors were recorded during the prescribing, monitoring, dispensing and administering 
processes.  The environmental and methodology variations between this audit and CHUMS 
study may be responsible for the differences in the frequency of discrepancies between this 
study and the CHUMS study.  Therefore, it is hard to compare, even though the same 
classification system was used.  Despite of variation between this audit and other studies 
reporting medication errors in TTOs, the proportion of discrepancies that reported by this 
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audit is located within the range of general errors (4.2-82%) reported from a systemic review 
studies of previous studies (106).   
 
Explained discrepancies are an intended addition or when a patient refuses their medication.  
These discrepancies are difficult to spot and may happen after the transcribers has written the 
unauthorised TTO.  To identify these discrepancies the pharmacists need to clarify the details 
on the unauthorised TTO with the doctor.  Unexpected addition of drug were classified as 
discrepancies because they were not documented, however, the reason for this being an 
explained discrepancy is because these are often added because the doctor would speak 
directly to the person writing the authorised TTO and would have agreed to add it and 
therefore it impossible to classify in any other way.  In three cases doctors added medication 
that was not documented on the drug charts or medical notes, to TTO’s written by 
pharmacists.  Reasons for these additions included a reasonable patient request for 
medication such as painkillers, a change in the patient clinical condition or extra medication 
was required to those originally prescribed.   
 
Patient refusal is any situation where it was documented that the patent refused medication 
throughout their stay and it was still written on the TTO.  Often, if a patient refuses 
medication there is little hospital personnel can do to change their mind, therefore, it is 
questionable whether a patient refusal should be classes a discrepancy.  Hospital policy at 
NNUH tells the pharmacists to “use their professional judgement and available sources of 
information to review the appropriateness of the current medication on the inpatient drug 
chart and intention to continue on discharge” (107).  If they are unsure about removing a 
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refused medication, or making other amendments to the drugs they will consult a doctor.  In 
some cases the patient’s doctor still insists this medication is transcribed on the TTO.  This 
may create wastage in the future as the  General Practitioner (GP), may re-prescribe since the 
patient was discharged from hospital with that medication (108-110).  Previous research into 
the discrepancies on TTO’s have not discussed patient refused medications (during in-patient 
time).  This audit has considered patient refusal.  Since all the explained discrepancies are not 
always the fault of the transcribers and one could question if these should be classified as 
discrepancies.  These were therefore excluded from the final regression analysis. 
 
Of the unexplained discrepancies, omission was the most common.  One reason for required 
medications being omitted is that they are missed of the admission prescription and 
admission notes (111).  Other reasons for omissions are when medications are missed from 
the drug history or the drug chart.  Omission can occur when necessary medication for the 
appropriate care of hospitalised individuals is not prescribed (112).  Unexplained 
discrepancies have been explored further in the (section 4.4). 
 
6.3.1 Discrepancies and wards 
The audit, transcribing activity and discrepancies was noted to be different between the 
wards.  For example, most of the omissions were produced from the surgical ward and nurses 
transcribe mainly in this location.  Also, most of patient refusals appear on the surgical ward, 
as most medication in surgical ward includes antibiotic and painkillers.  Painkillers are often 
refused by patients when they are not in pain or are concerned about addiction from pain 
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medication (113).  There were a smaller percentage of discrepancies on the urology and 
elective cardiology ward.  Most of the cases on this ward were admitted under a 
preadmission plan (114).  Therefore, it could be that planned admission may be associated 
with fewer discrepancies. 
 
Each clinical specialism varies in complexity and while this study did not capture the true 
nature of the complexity of each case, this may have contributed to the potential for 
discrepancies and variation between wards. 
 
6.3.2 Discrepancies and length of stay 
As the length of stay increased there were a greater number of discrepancies, particularly 
dose/strength discrepancies.  A possible reason for this, is the longer a patients stays in 
hospital the larger their medical notes and the amount of information on their stay, this may 
make it harder for transcribers to identify and interpret the correct medication, dose and 
strength. 
 
6.3.3 Discrepancies and type of medication 
The audit included a wide variety of medication from the majority of chapters of the BNF.  
The frequency of prescribing the different types of medication is probably linked to the 
clinical specialism of the wards included in the audit, but also links to the common medicines 
prescribed on discharge from hospital (115).  While the proportion of explained 
discrepancies was highest with central nervous system medication this is likely to be a result 
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of pain killers and the issues discussed in section 6.3.1.  Medicines prescribed from the 
cardiology chapter of the BNF had the highest number of unexplained errors and further 
research is needed to understand the reasons for this.  Possible explanations include patients 
with conditions requiring cardiology medicines are more complex; or that on non cardiology 
ward areas, these medicine are not considered by transcribers and thus results in more 
discrepancies. 
 
6.3.4 Discrepancies and transcribers 
Ideally, highly experienced transcribers (in the doctor, pharmacist and nurse groups) should 
make fewer mistakes.  However, paying experienced professionals is more expensive than 
paying those with less experience.  This audit consists of TTO’s written by transcribers of 
varying levels of experience but analysis of experience was not possible.  Therefore 
alternative considerations for variation in discrepancies need to be considered. 
 
The audit was mainly reliant on the outcomes of the pharmacist’s checks when authorising 
the TTO to identify discrepancies due to the limited clinical experience of the researcher.  
The study results show that fewer discrepancies were made by pharmacists but we should 
consider the potential for bias in this approach.  Pharmacists checking TTOs written by other 
transcribers follow a standard approach to complete the clinical check which is completely 
independent of the transcriber.  When a pharmacist authorises (clinical checks) a TTO 
written by themselves they are not independent of the process and in practice the doctors 
authorisation of this TTO is usually automatic, without following a full checking procedure 
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similar to the pharmacist’s clinical check.  Therefore pharmacists transcribed TTOs rely on 
pharmacy technicians performing a technician/dispensing check to identify any 
discrepancies.  This audit has not investigated errors which were dispensed to the patient and 
therefore there may be more errors from pharmacist transcribing at this stage.  Since 
authorisation of TTOs by pharmacists was conducted by a large number of pharmacists with 
varying levels of experience there may not be consistency in the number of discrepancies 
identified, even though the researcher tried to standardise this limitation. 
 
Another consideration for variation in transcriber discrepancies could be the work 
environment.  Factors such as noise, distractions and comfort may contribute to discrepancies 
not captured by this audit.  In addition, the general workload and time constraints of the 
transcriber may influence their ability to focus on transcribing and consequently contribute to 
more discrepancies.  Previous research has identified that because doctors are aware the TTO 
will have a second check by a pharmacist they don’t always give their full attention to 
transcribing (65).  Although in general, longer stays in hospital resulted in greater 
discrepancies, wards with particularly high turnover (short stay) may also contribute to 
discrepancies due to work load.  Pharmacist on ward B (urology/elective cardiology, a short 
stay ward) made more discrepancies that other ward areas and in busy wards doctors often 
use alternative transcribers to save their own time (82).  
 
Throughout this audit the variation between the patients is the likely to be the major reason 
for variation in discrepancies. Factors such as ward type, length of stay and type of 
medication have already been discussed but one must also consider the number of medication 
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prescribed.  Patient prescribed more medication are at risk of more discrepancies as each 
individual medication could be incorrect.  Nurses prescribed for patients with the highest 
median number of medications and they made the most discrepancies. 
 
The final major consideration for variation in discrepancies between the different healthcare 
professionals is the professional skills, knowledge and training.  Since pharmacists are used 
to identify issues with prescriptions, they may be better at transcribing them as they are 
familiar with the common problems that occur.  Larkin et al. reported that 56% of 
prescriptions written by a doctor needed amendments when clinical checked by a pharmacist 
(116).  In the only other study which has tried to directly compare different transcribers of 
discharge prescriptions (TTO), Rahman et al. identified that pharmacists made fewer errors 
than doctors however this study also had a number of limitations as the method of detecting 
discrepancies in each group was not the same (83).  
 
6.4 Regression 
To try to overcome lack of comparability between the groups, regression analysis was used 
to enable adjustments for potential predictors of discrepancies and identify the significant 
predictors of discrepancies in light of considering all other factors.  Two significant 
predictors of discrepancies were identified following the logistic regression which was nurse 
transcribers compared to pharmacist and the time delay between writing the unauthorised and 
authorised TTO being greater three hours.   
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The first significant predictor of discrepancies was if there was a delay of more than three 
hours between writing the unauthorised TTO and it being authorised.  It is hospital policy for 
ward pharmacists to check every unauthorised TTO.  Once the TTO has been checked, the 
pharmacist must authorise it.  The authorised TTO is then sent to the pharmacy to be 
dispensed if it cannot be dispensed on the ward.  This means when a doctor or nurse creates a 
TTO, it should be held on the ward for a pharmacist to authorise.  This policy has a direct 
impact on the time between the unauthorised TTO being created and the TTO being 
authorised.  The time between unauthorised TTOs being authorised for doctors was 0.8 hours 
and 1.7 hours for nurses.  TTOs created by pharmacists were authorised straight away, which 
incurred no delay to the subsequent activities (such as patient discharge). There are a number 
of possible reasons why a TTO may not be authorised for a long time, many of these are 
genuine delays such as:  pharmacists are not available or the pharmacists are not contacted to 
authorise the TTO in a timely manner and a change in patient circumstances alters planned 
discharge and pharmacists are told not to authorise the TTO.  It is also important to consider 
that the more discrepancies within an unauthorised TTO will result in the TTO taking longer 
to correct before it can be authorised, increasing the time between unauthorised and 
authorisation from the pharmacist. 
 
When there is a long delay between an unauthorised TTO being authorised there is an 
increased chance of changes in the patient which will require other medicine changes.  In 
addition, the original transcriber/prescriber will be harder to contact as they are less likely to 
be available with the TTO.  This is why many hospitals offer an on call/bleep discharge 
pharmacy team to try to provide a more rapid discharge service and reduce the time between 
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unauthorised and authorised TTO (117).  When TTO are not authorised by the usual ward 
pharmacist it is likely that the process will take longer as alternative pharmacists will be less 
familiar with the patients. 
 
Secondly, when nurses write TTOs it seem that the odds of them making a discrepancy is 
three times more likely than if pharmacists had written the TTO.  This may be a results of 
many reasons such as, the lack of experience that nurse have when writing TTOs, they may 
need more training, they may have other important work to do in the ward or they may rely 
on pharmacists to check the TTO prior authorisation.  While the small sample size of nurses 
transcriber cannot make this result generalisable to nurses, other possible considerations 
should be made.  Nurses transcribers were mainly working on surgical wards which may 
focus their attention on medication associated with the surgical procedures experienced by 
the patient.  Therefore the majority of the discrepancies may be associated with the patients’ 
long term medication which is not considered by the surgical team. 
 
Finally, while doctors did not quite reach the usual convention for statistical significance they 
remained in the model and were two times more likely to have discrepancies than 
pharmacists.  Other important predictors to consider from the model were patients prescribed 
between 11-15 medications or aged between 50 to 60 years has an increased change of 
discrepancies.  Therefore future studies which investigate different transcribers of TTOs 
should consider these factors if a full randomised trial is not feasible. 
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6.5 Limitation of the study 
This study found pharmacists making fewer discrepancies on discharge prescriptions (TTO) 
in comparison to doctors and nurses.  However, a number of limitations mean that our results 
should be interpreted with caution.   
 
Despite the researcher undertaking one week of training in spotting discrepancies and 
extracting information from patients medication documents at the beginning of the audit, 
there was still the potential for the researcher to miss discrepancies due to their limited 
clinical experience. Only the researcher reviewed the TTOs – having at least one other 
researcher review them, ideally with more clinical experience, would have increased the 
accuracy of the audit.  
 
Pharmacists were aware of the audits aims and knowing that their TTOs were to be reviewed 
may have increased their attention to detail, thus affecting the results in favour of 
pharmacists making fewer discrepancies. Bias may have been introduced due to doctors and 
nurses being less aware of the audit, thus they did not give as much attention to detail as the 
pharmacists. 
 
The training, experience (i.e. grades) and number of TTOs between the three groups of 
transcriber vary and cause confusion when making comparisons. Pharmacists are not eligible 
for qualifying as independent prescribers until two years post-registration and nurses have to 
have three years post-registration clinical experience.  Pharmacist should have at least two 
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years experience in hospital pharmacy and/or a post-graduate certificate/diploma in clinical 
pharmacy in order to be able to write the TTO.  Both pharmacists and nurses undergo a 
supervised twelve day prescribing course. Doctors are able to prescribe from day 1 of being a 
junior doctor.  
 
Pharmacists will have learnt more about medicines than nurses throughout their career and 
by working in pharmacy, are likely to be aware of common discrepancies; their experience 
may make them less likely to make the same discrepancies. Nurses may also have been 
exposed to common discrepancies in their career prior to qualification as a nurse independent 
prescriber. Junior doctors may be disadvantaged in that they do not spend as long time on a 
particular ward (and area of medicine) than the pharmacists and nurses, and are less aware of 
discrepancies commonly made.  
 
The audit does not necessary account for which transcriber group makes the most 
discrepancies when working independently; the transcriber groups may have sought help 
when transcribing from a colleague in either their own transcriber group, or another. It is well 
known that junior doctors are helped a lot by nurses in hospital, and pharmacists often 
comment that they help junior doctors with medicine related issues.   
 
There was a only a small difference in the median number of medications transcribed from 
the three transcriber groups, however the three groups of transcriber predominately 
transcribed medicines from different BNF chapters (i.e. different types of medication).  It is 
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difficult to say with certainty whether the results of this audit are related to these differences 
or the accuracy of the transcriber groups. 
 
The three wards in the audit differed in their speciality and rate of admission and discharge, 
with a significant difference in patient length of stay. A different clinical circumstance on 
each ward, as well as an unequal number of TTOs reviewed by each type of transcriber from 
each ward, makes comparison between the three groups difficult. In some cases the 
maximum transcribed medication was twenty-four, with the minimum being one. In 
polypharmacy each medicine included has potential discrepancies, so transcribers prescribing 
larger quantities of medication intrinsically had more potential discrepancies 
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Chapter 7 
Conclusion 
Overall this study demonstrates the using pharmacist transcribers is at least as safe as 
previous systems and is unlikely to introduce additional discrepancies.  However the 
variation in the sample and the methods employed limit the generalisaibility of the result and 
the conclusions which can be made.  The regression analysis has however identified 
important variables which must be considered when designing any future studies.  Nurse 
transcribers appear three times more likely to introduce discrepancies than pharmacist and 
therefore addition support is particularly needed for this transcriber group, since they cannot 
be reliant on the pharmacist second check all the time.  Alternative approaches which support 
the healthcare team to work closer together at the time of discharge should reduce delays 
authorising the TTO and reduce discrepancies. 
 
7.1 Recommendations 
7.1.1 Recommendations for hospital 
The main findings of this audit are supported by previous research, with promising results 
seen for pharmacists; they wrote fewer TTOs containing discrepancies in comparison to 
doctors and nurses. Therefore, it can be said that pharmacists should transcribe TTOs to 
improve patient safety, this is likely to lower costs and improve efficiency.  
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Many patients refuse to take one or more of their medications during their in-patient period. 
Despite this, transcribers still transcribe these medications on TTOs wanting the patients to 
go home with them. This study recommends that transcribers do not include such medication 
on TTOs and communicate the situation to the patients GP. Should a patient then decide that 
they will take their medication; the GP can prescribe it to them. This approach is likely to 
reduce medicine wastage.   
 
Taking the drug history of patients at the beginning of admission helps prescribers prescribe 
appropriate medication and to stop medication no longer required. The drug histories ensure 
the continuity of medicines for those who are admitted with serious health problems and 
delays are avoided where patients are unable to remember their medication details or unable 
to communicate.  The drug chart appears to be the key document in the transcribing of TTOs 
and therefore it is vital this is up to date and correct.  Therefore hospitals should follow the 
recommendations for medicines reconciliation from National Patient Safety Agency/National 
Institute for Health and Clinical Excellence  NPSA/NICE (118, 119). 
 
It would appear that long delays in authorising TTO may contribute to an increased risk of 
discrepancies and therefore the faster the hospital can authorised TTO the fewer 
discrepancies should occur.  Greater resources in rapid discharge teams may support this 
process.  
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7.1.2 Recommendations for further study 
For future studies to identify the transcriber who produces the least discrepancies in TTOs a 
randomised controlled trial design would be ideal.  However it is unlikely that this study 
design would be feasible, therefore future studies need to consider the important predictors of 
discrepancies identified in this study and control for them as far as possible (other than 
transcriber).  This may be a matched cohort design where cases are matched retrospectively 
for patient age, number of medication, and as far as possible ward and clinical condition of 
the patient.  It would also be more appropriate to consider the experience of the transcriber, 
however this may be best captured in an economic evaluation. 
 
An additional study should consider the economics of different models of transcribing to 
determine the cost of the different transcribers and the discrepancies made. The most cost 
efficient service may use staff with higher salaries or experience because this results in less 
discrepancies or the converse may apply.  Other factors to consider in an economic 
evaluation are the impact of patient refused medication and including this on a TTO. 
 
The relationship between drug chart quality and TTO quality should be investigated as well 
as whether the drug charts contain all the required information to produce accurate TTOs.  
This further work to explore the benefit of medicines reconciliation is required. 
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Table A-1  Classification of errors 
Type Code Sub type Code 
(1) 
Omission 
1 
Failure to prescribe a drug that has been 
previously prescribed or had been initiated by 
another health care professional and which was 
not intentionally stopped by prescriber, or failure 
to prescribe a drug that was clinically indicated 
1 
Drug is 
documented in 
drug chart and 
medical note 
2 
Drug is not 
documented in 
drug chart and 
medical note 
(2) 
Patient incorrect 
2 Prescribing for the wrong patient 3 
(3) 
Unnecessary 
drug 
3 
Prescribing a drug for which there is no 
indication. Note that not all diagnoses are always 
written in the notes. Excludes when residents 
and/or relatives put pressure on the GP to 
prescribe an unnecessary drug 
4 
Patient refusal 
5 
Extra medication 
(4) 
Duplication 
4 
Two drugs which have the same action are 
prescribed together in 
error e.g. generic and branded, two different 
statins, two different forms of the same drug. 
Excludes intentional prescribing e.g. 
anti‐Parkinsonism drugs 
6 
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Table A-2  Classification of errors 
Type Code Sub type Code 
(5) 
Drug incorrect 
5 
Choosing the wrong drug e.g. when two drugs have similar 
names 
7 
    
(6) 
Allergy error 
Contraindication 
6 
Prescribing a drug for which the patient has a known drug 
allergy 
8 
Prescribing a drug which is contraindicated because of a 
coexisting clinical condition 
9 
(7) 
Interaction 
7 
Prescribing a drug which may cause a serious drug 
interaction, 
unless this was a recognised risk and appropriate action 
taken to 
reduce risk e.g. if two interacting drugs were both 
considered essential for patient and dose adjustments had 
been made or a further drug added to address this 
10 
 
 
 
 
Table A-3  Classification of errors 
Type Code Sub type Code 
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(8) 
Dose/strength 
error 
8 
Prescribing a drug in a dose above or below that appropriate 
for that patient and/or for their clinical condition 
11 
(9) 
Formulation error 
9 
Prescribing a drug in a formulation that is unsuitable for the 
route of administration including modified release 
preparations for administration via a PEG tube 
12 
(10) 
Frequency error 
10 
Prescribing a drug for which the frequency is inappropriate 
and 
would result in a sub‐therapeutic effect or risk of toxicity 
13 
(11) 
Timing error 
11 
Prescribing a drug for a time which is unsuitable for that 
preparation e.g. prescribing Simvastatin in the morning 
14 
(12) 
Information 
incomplete 
12 
Omission of strength for drugs available in more than one 
strength. 
15 
Omission of route for drugs that can be given by more than 
one 
route e.g. eye, ear and nose drops.  
16 
Patient name omitted. 17 
Omission of maximum daily dosing frequency for an “as 
required “ medicine when overdose could result in harm.  
18 
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Table A-4  Classification of errors 
Type Code Sub type Code 
    
(12) 
Information 
incomplete 
12 
Omission of directions for 
correct administration (eg prescribing GTN tablets “as 
directed” 
19 
(13) 
MAR 
transcription 
error 
13 
Poor transcription on to the MAR by the prescriber which 
results in an error e.g. use of Latin abbreviations on MAR in 
a residential home 
20 
(14) 
Other 
14 Record anything else that is not covered in the above 21 
(15) 
Linked error 
15 
To be used if a prescribing error is linked to another error 
e.g. 
prescription and dispensing of penicillin to a penicillin 
allergic 
patient 
22 
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Appendix B 
Data Collection sheet 
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Audit No:  Age:   Gender: Male  Female   date:___/___/_____   Time: 
Prescriber: (1-doctor, 2 = nurse, 3 - pharmacist) Grade / Band:   No of reg. medicines: ____  No. of PRN medicines: 
___ 
Admission Date: ___/___/_____ Admission Time:   Discharge Date: ___/___/_____ Discharge Time:    
EDD: ___/___/_____   Length of Stay: _____ days   
Unauthorised TTO Date:___/___/____Unauthorised TTO Time:            Authorised TTO Date:___/___/____Authorised TTO Time: 
 
 
Unauthorised TTO information Authorised TTO information 
TTO information 
Errors classification No of 
errors/medic
ation 
No Name Dose Frequency Route Duration Dose Frequency Route Duration Error Error  
Error Sub,type Error Sub,type   
1                
2                
3                
4                
5                
6                
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Audit No 
 
Authorised TTO information 
TTO information 
Inpatient prescription chart / 
medical note discrepancies 
Errors classification No of errors/medication 
No Name Dose Frequency Route Duration Error Error  
Error Subtype Error Subtype   
1             
2             
3             
4             
5             
6             
7             
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Appendix sheet C 
Encryption sheet
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Audit No. Hospital No. NHS No. 
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1. Introduction 
Medication error is one of the major reasons for mortality worldwide, and is the most common type of 
medical error. Medication error is defined as any error in the process of prescribing, dispensing or 
administering a drug, whether there are adverse consequences or not (1). In the United States, it is the 
eighth leading cause of death and is responsible for between 44,000 to 98,000 deaths each year (2). The 
consequence of medication error is – in many cases – the patient’s life; with the financial cost for 
450,000 preventable medication related incidents in American hospitals estimated to be US$3.5 billion 
each year (2).  
 
In the UK, one of the divisions of the National Patient Safety Agency (NPSA), the National Reporting 
and Learning Services (NRLS), aims to improve patient safety and reduce risk to patients receiving 
NHS services through its national reporting system. They define a medication errors as “an error in the 
process of prescribing, dispensing, preparing, administrating, monitoring or providing medicine advice, 
regardless of whether any harm has occurred” (3). They classify medication errors into two groups: 
adverse events and near misses (meaning no harm was caused or the incident was averted).   It is 
estimated that about 9% of inpatients are exposed to medication-related harm at some point, but most 
of these cases could and should be prevented (4). Between January 2005 and June 2006, the number of 
medication error incidents reported by NPSA was 60,000, a figure that costs the NHS more than £750 
million a year (4).  However there is probably significant under reporting of medication errors, often 
because staff may be unaware that medication errors have occurred (4). 
 
At the time of hospital discharge, medication discrepancies, lack of information and clarity and 
inaccuracies in discharge summaries are common and may affect the quality of care (5). Callen et al. 
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performed a retrospective study of discharge summaries in an Australian metropolitan hospital in 2009 
(6). They compared 966 handwritten to 842 typed discharge summaries.  In both types of discharge 
summary the medication section had been transcribed from inpatient records.  An independent review 
of these records identified 12.1% error rate in handwritten summaries and 13.3% in typed summaries. 
Consequently 25% of discharge summaries contained medication errors.  The authors support the role 
of the hospital pharmacist in checking prescriptions to reduce errors. Similar results were identified in 
Canada (7) where  approximately 25% of patients had adverse within five weeks of leaving  hospital 
and in Ireland, a review of 139 discharges identified medication errors in 11% of prescriptions (5). 
Greater concern are the results from a study in Denmark (8) where the authors suggest there is a 75% 
chance of a medication error occurring in a discharge prescription.   
 
In the UK research has been limited by small sample sizes, but they still highlight the problems of 
medication errors at discharge.  A small study  in Kent investigated medication errors during transfer of 
43 patient from primary care to secondary care (9).  This study examined the medication list before and 
during admission, the medication list used for dispensing by pharmacy and the medication list on 
discharge summary.  Among 43 patients, medication errors were founded in 39 patients at one or more 
stages of the transfer of information between primary and secondary care. The above studies 
demonstrate that errors in discharge prescriptions are common and universal.  
 
Pharmacist play an important role in checking patient medication before discharge and they detect most 
of the medication errors in discharge summaries (10, 11).  In Landskrona hospital in Sweden, after the 
physician had completed the discharge summary, clinical pharmacists evaluated the discharge summary 
including the medication report by comparing it to a developed checklist. By giving feedback to the 
physician, this practice reduced medication errors on the final discharge summary by 45% (12).  There 
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are numerous reasons why a discharge summary may contain errors when written by a doctor which 
include: routine violations of prescribing rules, work load pressures, miscommunication, deficiencies of 
knowledge or skill and moreover a reliance on pharmacists and nurses to correct errors  (13).  While 
pharmacy has always provided a second check to discharge summaries, there have recently been 
increases in the number of pharmacists and nurses who perform the transcribing role for medication on 
discharge summaries (14, 15). 
 
Pharmacists are the medicines experts, and their training, skills and knowledge make them suitable to 
transcribe discharge prescriptions.  On other hand nurses is taking a role in transcribing discharge 
summaries and reducing medication errors from 22 to 8%(120).  While this process has been 
implemented in many hospitals to increase the speed of discharge, few studies have investigated the 
quality of these discharge summaries  (17, 18).  Rahman et al. compared discharge summaries written 
by pharmacists to those written by doctors (19).  The study occurred in two phases; phase one (week 
one) doctors wrote 128 discharge prescriptions that were checked for errors by study pharmacists 
before going to the pharmacy dispensary for the usual checks and dispensing.  In phase two the clinical 
pharmacist wrote 133 discharge summaries, these were checked for errors by the study doctors before 
being sent to pharmacy for their usual checks and dispensing. In the first phase there were 755 
interventions, compared to only 76 interventions in the second phase.  The authors concluded that 
pharmacists are better than doctors in writing discharge prescription.  However the study design means 
that patient groups may not have been comparable and the identification of errors would have been 
limited in phase two as this does not form part of the usual work of a doctor.   
 
Currently, at the Norfolk and Norwich University Hospital (NNUH) all patient admitted are given an 
estimated discharge date (EDD).  At discharge the unauthorised discharge prescription can be prepared 
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by doctors, pharmacists or nurses, depending on the ward.  The unauthorised discharge summary is 
clinically checked by the pharmacy department and authorised before the medication is dispensed and 
the patient discharged.  The aim of this audit is to compare the quality of the discharge summaries 
written by different healthcare professionals.  Although there are many systems used to classify errors 
(20, 21) the American Society of Health System Pharmacy (ASHP) provides a classification system 
(appendix 1) which is widely adopted (22) and will therefore be used in this audit.   
 
2.  Aim and audit standards 
 To compare the quality of discharge prescriptions (TTOs) written by doctors, nurses and 
pharmacists and adherence to audit standards. 
 
2.1 Audit standards 
1. 100% of unauthorised discharge summaries contain no errors identify by pharmacy (authorised 
discharge summary) (see appendix 1 for classification of errors)  
2. 100% of authorised discharge summaries contain no errors identify by researcher from medical 
notes and inpatient prescription chart (see appendix 1 for classification of errors)  
 
3. Method 
Appropriate approvals will be obtained before commencing this audit at the Norfolk and Norwich 
University Hospital (NNUH) on three wards A, B and C.  These wards have been selected because 
between these wards they already have discharges written by doctors, pharmacists and nurses and cover 
a wide range of specialisms.  On these wards it is estimated that approximately 12 discharge summaries 
are transcribed by doctors, 12 by pharmacists and 3 by nurses each day. 
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Pilot data collection will take place in November 2010 and 10 discharge summaries written by a doctor, 
pharmacist and nurse will be included.  Following pilot data collection a total of 60 discharge 
summaries will be included in this audit.  A flow charge of the audit design is included in figure 1.  The 
inclusion and exclusion criteria of selected participants are: 
 
Inclusion criteria: 
 Aged over 18 years 
 Patients who have been discharge with medication 
 
Exclusion criteria: 
 Full notes and prescription chart not available at time of discharge 
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Figure 1     Research Design Flow Chart 
Discharges on Ward A Ward B and C, 
 written by: Pharmacist, Nurse or Doctors 
Identified in Pharmacy 
as matching 
inclusion/exclusion 
criteria 
Compare 
Medical note  
+  
Inpatient 
prescription 
chart 
Identify and 
classify 
 
 Recording 
discrepancies 
Compare 
Data analysis 
 
Unauthorized 
TTOs  
Authorize
d TTOs 
by 
pharmacis
t 
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The audit will be divided in to two phases. 
 
3.1 Phase 1: Audit of medication errors in unauthorised summaries 
An audit will be performed which compares unauthorised discharge summaries (discharges 
summaries sent to pharmacy to be authorised) and authorised summaries (discharge 
summaries ready to be sent to primary care).  All errors/discrepancies will be categorised for 
research purposes using adapted ASHP classification (22). 
 
Audit standards 
 
3.1.2 Data collection  
All original unauthorised discharge prescriptions will be retained by the pharmacy 
department following current procedures (Original unauthorised discharge prescriptions will 
be retained in data collection even if they are reprinted prior to dispensing due to significant 
changes during clinical check).  During data collection these will not be destroyed untill they 
have been reviewed by the researcher.  The researcher will review unauthorised discharge 
prescriptions between 1-3pm each week day.  Every third discharge summary from each 
healthcare professional which matches the inclusion/exclusion criteria will be included in the 
audit.  For each included discharge summaries copies of the inpatient prescription chart and 
last five days of their medical notes will be taken and anonymised in addition to a copy of 
their authorised discharge summary.  Dates of unauthorised discharge prescription will be 
extracted from the audit log on the electronic hospital records. 
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For all included patients the following information will be obtained from the discharge 
summary, medical notes and inpatient prescription chart: 
 Audit Number 
 Time and date of admission  
 Time and date of estimated discharge (EDD) 
 Date of discharge 
 Patient’s Age 
 Patient’s gender 
 Number of Regular medications 
 Number of PRN medications 
 Details of medicines prescribed 
 Grade/Band of discharge prescription transcribe (obtained from consultation with 
hospital staff) 
 
This information will be collected on a data collection sheet (appendix 3).  The patient’s 
hospital number and audit number will be recorded on a separate encryption form (appendix 
2) which will be stored in the pharmacy department in the rare event that notes need to be 
referred back to at a later date.  Only anonymised data on the data collection form will leave 
the hospital. 
 
3.2 Phase 2: Independent audit of authorised discharge summaries 
Utilising the same data and patients as identified in phase one.  A researcher will compare 
authorised discharge summaries with the inpatient prescription charts and medical notes to 
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identify if any errors have occurred., Identified errors will be communicated to the clinical 
pharmacist and categorised for research purposes using adapted ASHP classification (22).  A 
random sample of 10% of researcher audits will be verified by a clinical pharmacist for 
accuracy. 
 
3.2.1 Data collection 
No additional data will be collected in Phase two, all anonymised copies of medical notes 
and inpatient prescription charts will be stored in the pharmacy department for verification as 
required.  Any errors identified in phase two will be reviewed by a senior hospital clinical 
pharmacist and appropriate action taken if necessary.  A 10% sample of reviewed 
prescriptions will be verified for accuracy by a senior clinical pharmacist at the hospital. 
 
3.3 Sample size estimation 
The pilot will not allow detailed analysis of errors.  This pilot is designed to determine the 
feasibility of data collection and determine if there is any significant bias in the patient 
populations discharge by the different healthcare professionals.  It is anticipated that pilot 
data collection will take no longer than one week to complete. 
 
To detect a 20% of differences in errors based on assumption that the error rate in one group 
is 10% and the other is 30%; then data from 59 patients is required in each group to detect 
the differences with 80% power at 5% significant level.  
3.4 Patient confidentiality and data storage 
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All patients will be coded with an audit number using the encryption form (appendix 2) 
which links to patient identifiable information; this will be stored in the pharmacy 
department under normal storage procedures.  All documents used in this audit (unauthorized 
and authorized discharge prescriptions, medical notes, inpatient prescription chart) and any 
copies of them will also be stored in the hospital.  Only encrypted data on the data collection 
sheet will be taken away for analysis.  Once the audit is completed and data verified all 
copied data will be placed in the pharmacy department confidential waste. 
 
3.5  Data Analysis 
Patient demographics will be described using descriptive data analysis and compared 
between different healthcare professionals using observation of the confidence intervals.  
Errors identified in phase 1 and phase 2 will also be described with descriptive statistics and 
compared using observation of the confidence intervals.  Chi squared analysis will compare 
the number and type of errors between each healthcare professional in each phase of the 
audit. 
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